| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | CITED2 BCL9L NCOR1 KMT2C NCOA6 ARID1B DDX17 ZMIZ2 MED8 KAT6A RBM14 MAML1 MED12L SMARCA4 WWTR1 MAML2 BCL9 BCOR MIDEAS TBL1XR1 NIPBL MAML3 SF1 EP300 | 3.67e-18 | 562 | 83 | 24 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | CITED2 BCL9L KMT2C NCOA6 ARID1B DDX17 ZMIZ2 KAT6A RBM14 MAML1 MED12L SMARCA4 WWTR1 MAML2 BCL9 MAML3 EP300 | 6.33e-15 | 303 | 83 | 17 | GO:0003713 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | CITED2 BCL9L NCOR1 KMT2C NCOA6 NMNAT2 ARID1B DDX17 PIK3R1 ZMIZ2 MED8 KAT6A TNRC6A RBM14 MAML1 MED12L SMARCA4 WWTR1 MAML2 FLRT1 BCL9 BCOR MIDEAS TBL1XR1 NIPBL MAML3 SF1 EP300 | 8.39e-15 | 1160 | 83 | 28 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | CITED2 BCL9L NCOR1 KMT2C NCOA6 NMNAT2 ARID1B DDX17 PIK3R1 ZMIZ2 MED8 KAT6A TNRC6A RBM14 MAML1 MED12L SMARCA4 WWTR1 MAML2 FLRT1 BCL9 BCOR MIDEAS TBL1XR1 NIPBL MAML3 SF1 EP300 | 4.01e-13 | 1356 | 83 | 28 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 4.62e-07 | 229 | 83 | 9 | GO:0003714 | |
| GeneOntologyMolecularFunction | chromatin binding | CITED2 NCOR1 NCOA6 ARID1B DDX17 MAZ KAT6A SMARCA4 ANKRD17 TSPYL5 CHD8 NFAT5 NIPBL EP300 | 1.98e-06 | 739 | 83 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.08e-05 | 120 | 83 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 6.96e-05 | 53 | 83 | 4 | GO:0030331 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 8.73e-05 | 21 | 83 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.29e-04 | 187 | 83 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | transcription factor binding | CITED2 NCOR1 NCOA6 LATS1 PIK3R1 KAT6A MED12L SMARCA4 BCOR NFAT5 EP300 | 2.77e-04 | 753 | 83 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.86e-04 | 37 | 83 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.89e-04 | 582 | 83 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.73e-03 | 15 | 83 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.75e-03 | 417 | 83 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 2.09e-03 | 61 | 83 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor binding | 2.50e-03 | 18 | 83 | 2 | GO:0005159 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 3.09e-03 | 20 | 83 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | protein domain specific binding | CITED2 NCOR1 NCOA6 CTTNBP2 ATXN2 USHBP1 PIK3R1 CHD8 GNAS NIPBL | 3.34e-03 | 875 | 83 | 10 | GO:0019904 |
| GeneOntologyMolecularFunction | p53 binding | 4.06e-03 | 77 | 83 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 4.08e-03 | 23 | 83 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 4.08e-03 | 23 | 83 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 4.21e-03 | 78 | 83 | 3 | GO:0008080 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CITED2 BCL9L KMT2C NCOA6 DDX17 PIK3R1 ZMIZ2 MAZ MED8 CAPRIN2 RBM14 MAML1 MED12L SMARCA4 CHD8 WWTR1 SSBP2 POGZ MAML2 PAX7 BCL9 NFAT5 TBL1XR1 NIPBL MAML3 EP300 | 8.53e-12 | 1390 | 81 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | NCOR1 KMT2C ARID1B CECR2 MED8 KAT6A NFRKB RBM14 SMARCA4 TSPYL5 CHD8 POGZ PAX7 GNAS BCOR NFAT5 TBL1XR1 ZBTB1 NIPBL EP300 | 1.18e-09 | 999 | 81 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | NCOR1 KMT2C ARID1B CECR2 KAT6A NFRKB RBM14 SMARCA4 TSPYL5 CHD8 PAX7 GNAS BCOR NFAT5 TBL1XR1 ZBTB1 NIPBL EP300 | 8.83e-09 | 896 | 81 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | KMT2C ARID1B CECR2 KAT6A NFRKB RBM14 SMARCA4 TSPYL5 CHD8 PAX7 GNAS BCOR NFAT5 ZBTB1 NIPBL EP300 | 2.49e-08 | 741 | 81 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | chordate embryonic development | CITED2 NCOR1 NCOA6 SEC24D LATS1 CECR2 KIAA1217 SMARCA4 UNK CHD8 PAX7 GNAS BCOR TBL1XR1 NIPBL EP300 PRRC2B | 6.60e-08 | 906 | 81 | 17 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | CITED2 NCOR1 NCOA6 SEC24D LATS1 CECR2 KIAA1217 SMARCA4 UNK CHD8 PAX7 GNAS BCOR TBL1XR1 NIPBL EP300 PRRC2B | 9.47e-08 | 929 | 81 | 17 | GO:0009792 |
| GeneOntologyBiologicalProcess | embryo development | CITED2 NCOR1 NCOA6 SEC24D LATS1 CECR2 KIAA1217 KAT6A NFRKB RBM14 SMARCA4 UNK CHD8 PAX7 TNRC6C GNAS BCOR TBL1XR1 NIPBL EP300 PRRC2B | 1.04e-07 | 1437 | 81 | 21 | GO:0009790 |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.07e-06 | 136 | 81 | 7 | GO:0045445 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.36e-06 | 276 | 81 | 9 | GO:0007179 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 2.02e-06 | 7 | 81 | 3 | GO:0007221 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 6.07e-06 | 249 | 81 | 8 | GO:0035264 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 6.76e-06 | 336 | 81 | 9 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 7.98e-06 | 343 | 81 | 9 | GO:0071559 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.06e-05 | 192 | 81 | 7 | GO:0017015 | |
| GeneOntologyBiologicalProcess | developmental growth | CITED2 NCOR1 KMT2C LATS1 ATXN2 SMARCA4 WWTR1 FLRT1 PAX7 GNAS BCL9 TBL1XR1 NIPBL EP300 | 1.12e-05 | 911 | 81 | 14 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.17e-05 | 195 | 81 | 7 | GO:1903844 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | CITED2 BCL9L MTMR4 LATS1 ZMIZ2 WWTR1 TNRC6C BCL9 SAP130 EP300 | 1.88e-05 | 482 | 81 | 10 | GO:0007178 |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.06e-05 | 14 | 81 | 3 | GO:0060213 | |
| GeneOntologyBiologicalProcess | growth | CITED2 NCOR1 KMT2C LATS1 ATXN2 CAPRIN2 SMARCA4 WWTR1 FLRT1 PAX7 GNAS BCL9 TBL1XR1 NIPBL EP300 SH3BP4 | 2.07e-05 | 1235 | 81 | 16 | GO:0040007 |
| GeneOntologyBiologicalProcess | in utero embryonic development | CITED2 NCOR1 NCOA6 SEC24D LATS1 SMARCA4 UNK CHD8 BCOR TBL1XR1 PRRC2B | 2.07e-05 | 596 | 81 | 11 | GO:0001701 |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.15e-05 | 16 | 81 | 3 | GO:0060211 | |
| GeneOntologyBiologicalProcess | negative regulation of translation | 3.38e-05 | 230 | 81 | 7 | GO:0017148 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 3.47e-05 | 231 | 81 | 7 | GO:0006352 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 3.81e-05 | 96 | 81 | 5 | GO:0035914 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 4.79e-05 | 51 | 81 | 4 | GO:0030521 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 6.16e-05 | 344 | 81 | 8 | GO:0060070 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 6.17e-05 | 445 | 81 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 9.19e-05 | 186 | 81 | 6 | GO:0006367 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 1.17e-04 | 64 | 81 | 4 | GO:0010171 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.25e-04 | 65 | 81 | 4 | GO:0045815 | |
| GeneOntologyBiologicalProcess | regulation of translation | 1.36e-04 | 494 | 81 | 9 | GO:0006417 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.44e-04 | 202 | 81 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 1.48e-04 | 68 | 81 | 4 | GO:0141137 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 1.89e-04 | 516 | 81 | 9 | GO:0016055 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.98e-04 | 136 | 81 | 5 | GO:0030518 | |
| GeneOntologyBiologicalProcess | regulation of focal adhesion disassembly | 2.26e-04 | 6 | 81 | 2 | GO:0120182 | |
| GeneOntologyBiologicalProcess | positive regulation of focal adhesion disassembly | 2.26e-04 | 6 | 81 | 2 | GO:0120183 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 2.42e-04 | 31 | 81 | 3 | GO:0060765 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 2.47e-04 | 223 | 81 | 6 | GO:0007519 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 2.64e-04 | 540 | 81 | 9 | GO:1903706 | |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 2.67e-04 | 32 | 81 | 3 | GO:0035162 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 2.92e-04 | 33 | 81 | 3 | GO:0000289 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | CITED2 NCOR1 MAZ KAT6A SMARCA4 CHD8 WWTR1 BCOR MIDEAS TBL1XR1 SAP130 ZBTB1 NIPBL SF1 EP300 | 3.19e-04 | 1399 | 81 | 15 | GO:0045892 |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 3.36e-04 | 558 | 81 | 9 | GO:0030099 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 3.42e-04 | 237 | 81 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | chromosome organization | ARID1B LATS1 NAF1 KAT6A NFRKB SMARCA4 CHD8 POGZ NIPBL ANKRD53 | 3.47e-04 | 686 | 81 | 10 | GO:0051276 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | CITED2 NCOR1 MAZ KAT6A SMARCA4 CHD8 WWTR1 BCOR MIDEAS TBL1XR1 SAP130 ZBTB1 NIPBL SF1 EP300 | 3.55e-04 | 1413 | 81 | 15 | GO:1902679 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.63e-04 | 155 | 81 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 3.65e-04 | 240 | 81 | 6 | GO:0060538 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 3.82e-04 | 242 | 81 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 3.84e-04 | 87 | 81 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | definitive erythrocyte differentiation | 4.20e-04 | 8 | 81 | 2 | GO:0060318 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4.30e-04 | 347 | 81 | 7 | GO:0090092 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 4.44e-04 | 249 | 81 | 6 | GO:0065004 | |
| GeneOntologyBiologicalProcess | organism emergence from protective structure | 4.82e-04 | 39 | 81 | 3 | GO:0071684 | |
| GeneOntologyBiologicalProcess | hatching | 4.82e-04 | 39 | 81 | 3 | GO:0035188 | |
| GeneOntologyBiologicalProcess | blastocyst hatching | 4.82e-04 | 39 | 81 | 3 | GO:0001835 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 4.94e-04 | 93 | 81 | 4 | GO:0040014 | |
| GeneOntologyBiologicalProcess | muscle structure development | CITED2 BCL9L ARID1B DDX17 PIK3R1 MAML1 SMARCA4 ANKRD17 PAX7 BCL9 EP300 | 5.13e-04 | 858 | 81 | 11 | GO:0061061 |
| GeneOntologyBiologicalProcess | cell-substrate junction disassembly | 5.39e-04 | 9 | 81 | 2 | GO:0120180 | |
| GeneOntologyBiologicalProcess | focal adhesion disassembly | 5.39e-04 | 9 | 81 | 2 | GO:0120181 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 5.51e-04 | 475 | 81 | 8 | GO:0140694 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 5.59e-04 | 41 | 81 | 3 | GO:0060325 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 6.09e-04 | 368 | 81 | 7 | GO:0030111 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translation | 6.72e-04 | 10 | 81 | 2 | GO:2000766 | |
| GeneOntologyBiologicalProcess | blastocyst development | 7.00e-04 | 179 | 81 | 5 | GO:0001824 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 7.59e-04 | 382 | 81 | 7 | GO:0030217 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | CITED2 NCOR1 MAZ SMARCA4 CHD8 WWTR1 BCOR TBL1XR1 SAP130 ZBTB1 NIPBL EP300 | 8.01e-04 | 1053 | 81 | 12 | GO:0000122 |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 8.68e-04 | 108 | 81 | 4 | GO:0035019 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 8.68e-04 | 283 | 81 | 6 | GO:0045926 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 8.88e-04 | 48 | 81 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 9.00e-04 | 285 | 81 | 6 | GO:0060828 | |
| GeneOntologyBiologicalProcess | regulation of growth | CITED2 NCOR1 LATS1 ATXN2 CAPRIN2 SMARCA4 GNAS NIPBL EP300 SH3BP4 | 9.11e-04 | 777 | 81 | 10 | GO:0040008 |
| GeneOntologyBiologicalProcess | hemopoiesis | CITED2 SMAP1 NCOR1 NCOA6 ARID1B PIK3R1 KAT6A SMARCA4 TNRC6C GNAS DUX4L4 ZBTB1 EP300 | 9.11e-04 | 1223 | 81 | 13 | GO:0030097 |
| GeneOntologyBiologicalProcess | cellular response to radiation | 1.00e-03 | 194 | 81 | 5 | GO:0071478 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.18e-03 | 412 | 81 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 1.24e-03 | 119 | 81 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.24e-03 | 416 | 81 | 7 | GO:0030522 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 1.25e-03 | 54 | 81 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | DNA damage response | NCOA6 ARID1B PIK3R1 NFRKB SMARCA4 POGZ NFAT5 IMMP2L ZBTB1 NIPBL EP300 | 1.28e-03 | 959 | 81 | 11 | GO:0006974 |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 1.33e-03 | 421 | 81 | 7 | GO:0048638 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.34e-03 | 207 | 81 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.48e-03 | 429 | 81 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | BCL9L SMAP1 ARID1B PIK3R1 CAPRIN2 MAML1 SMARCA4 WWTR1 GNAS KCTD11 ZBTB1 EP300 | 1.60e-03 | 1141 | 81 | 12 | GO:0045597 |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.76e-03 | 16 | 81 | 2 | GO:1900153 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | CITED2 BCL9L MTMR4 LATS1 ZMIZ2 FLRT1 TNRC6C BCL9 SAP130 EP300 | 1.78e-03 | 850 | 81 | 10 | GO:0071363 |
| GeneOntologyBiologicalProcess | face development | 1.96e-03 | 63 | 81 | 3 | GO:0060324 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.97e-03 | 226 | 81 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | negative regulation of androgen receptor signaling pathway | 1.99e-03 | 17 | 81 | 2 | GO:0060766 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 1.99e-03 | 17 | 81 | 2 | GO:0043923 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organism growth | 1.99e-03 | 17 | 81 | 2 | GO:0040015 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.14e-03 | 65 | 81 | 3 | GO:0000288 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | CITED2 BCL9L MTMR4 LATS1 PIK3R1 ZMIZ2 WWTR1 FLRT1 TNRC6C BCL9 SAP130 EP300 | 2.21e-03 | 1186 | 81 | 12 | GO:0007167 |
| GeneOntologyBiologicalProcess | COPII-coated vesicle cargo loading | 2.24e-03 | 18 | 81 | 2 | GO:0090110 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 2.34e-03 | 465 | 81 | 7 | GO:0007059 | |
| GeneOntologyBiologicalProcess | response to growth factor | CITED2 BCL9L MTMR4 LATS1 ZMIZ2 FLRT1 TNRC6C BCL9 SAP130 EP300 | 2.36e-03 | 883 | 81 | 10 | GO:0070848 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L NCOR1 KMT2C NCOA6 ARID1B CECR2 MED8 NFRKB MED12L SMARCA4 CHD8 BCL9 BCOR MIDEAS TBL1XR1 SAP130 NIPBL DYDC2 SF1 | 1.41e-06 | 1377 | 83 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L NCOR1 NCOA6 MED8 RBM14 WWTR1 PAX7 BCL9 MIDEAS NFAT5 TBL1XR1 EP300 | 3.95e-06 | 596 | 83 | 12 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | CITED2 NCOR1 ARID1B CECR2 ZMIZ2 KAT6A HDX NFRKB SMARCA4 ANKRD17 TSPYL5 CHD8 POGZ PAX7 NFAT5 SAP130 NIPBL EP300 | 1.61e-05 | 1480 | 83 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.27e-04 | 75 | 83 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.66e-04 | 85 | 83 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.82e-04 | 96 | 83 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | bBAF complex | 6.87e-04 | 10 | 83 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | methyltransferase complex | 9.05e-04 | 108 | 83 | 4 | GO:0034708 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.00e-03 | 12 | 83 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.18e-03 | 13 | 83 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | npBAF complex | 1.37e-03 | 14 | 83 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | nuclear speck | 1.63e-03 | 431 | 83 | 7 | GO:0016607 | |
| GeneOntologyCellularComponent | ATPase complex | 1.75e-03 | 129 | 83 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 1.80e-03 | 16 | 83 | 2 | GO:0030127 | |
| GeneOntologyCellularComponent | nBAF complex | 1.80e-03 | 16 | 83 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | nuclear body | 3.02e-03 | 903 | 83 | 10 | GO:0016604 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.36e-03 | 269 | 83 | 5 | GO:0036464 | |
| HumanPheno | Thin vermilion border | SCYL2 CITED2 ARID1B KAT6A MED12L SMARCA4 TNRC6B ANKRD17 POGZ MAPRE2 TBL1XR1 NIPBL EP300 | 1.16e-07 | 433 | 28 | 13 | HP:0000233 |
| HumanPheno | Thin upper lip vermilion | ARID1B KAT6A MED12L SMARCA4 TNRC6B ANKRD17 POGZ MAPRE2 TBL1XR1 NIPBL EP300 | 7.43e-07 | 339 | 28 | 11 | HP:0000219 |
| HumanPheno | Thin lips | ARID1B KAT6A MED12L SMARCA4 TNRC6B ANKRD17 POGZ MAPRE2 TBL1XR1 NIPBL EP300 | 7.43e-07 | 339 | 28 | 11 | HP:0000213 |
| HumanPheno | Abnormal testis morphology | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 1.94e-06 | 1129 | 28 | 18 | HP:0000035 |
| HumanPheno | Triangular face | 2.00e-06 | 167 | 28 | 8 | HP:0000325 | |
| HumanPheno | Non-obstructive azoospermia | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 2.02e-06 | 1132 | 28 | 18 | HP:0011961 |
| HumanPheno | Abnormality of upper lip vermillion | ARID1B KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ MAPRE2 TBL1XR1 NIPBL EP300 | 2.22e-06 | 464 | 28 | 12 | HP:0011339 |
| HumanPheno | Azoospermia | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 2.83e-06 | 1157 | 28 | 18 | HP:0000027 |
| HumanPheno | Abnormality of dental eruption | 3.10e-06 | 240 | 28 | 9 | HP:0006292 | |
| HumanPheno | Prominent fingertip pads | 4.04e-06 | 46 | 28 | 5 | HP:0001212 | |
| HumanPheno | Abnormal male external genitalia morphology | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A MED12L SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 4.12e-06 | 1329 | 28 | 19 | HP:0000032 |
| HumanPheno | Abnormal spermatogenesis | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 4.36e-06 | 1190 | 28 | 18 | HP:0008669 |
| HumanPheno | Prominent digit pad | 5.01e-06 | 48 | 28 | 5 | HP:0011298 | |
| HumanPheno | Abnormal external genitalia | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A MED12L SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 6.88e-06 | 1372 | 28 | 19 | HP:0000811 |
| HumanPheno | Abnormal male internal genitalia morphology | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 8.46e-06 | 1243 | 28 | 18 | HP:0000022 |
| HumanPheno | Functional abnormality of male internal genitalia | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 1.16e-05 | 1269 | 28 | 18 | HP:0000025 |
| HumanPheno | Thick eyebrow | 1.40e-05 | 154 | 28 | 7 | HP:0000574 | |
| HumanPheno | Abnormality of the male genitalia | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A MED12L SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 1.44e-05 | 1437 | 28 | 19 | HP:0010461 |
| HumanPheno | Abnormal male reproductive system physiology | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 1.95e-05 | 1314 | 28 | 18 | HP:0012874 |
| HumanPheno | Autistic behavior | KMT2C ARID1B KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ BCOR TBL1XR1 NIPBL EP300 | 2.01e-05 | 678 | 28 | 13 | HP:0000729 |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | SCYL2 SEC24D ARID1B PIK3R1 KAT6A SMARCA4 TNRC6B CHD8 POGZ SEC31A FLRT1 PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 2.70e-05 | 1343 | 28 | 18 | HP:0009115 |
| HumanPheno | Severe expressive language delay | 3.17e-05 | 12 | 28 | 3 | HP:0006863 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 3.17e-05 | 12 | 28 | 3 | HP:0010746 | |
| HumanPheno | Abnormal facial shape | KMT2C SEC24D ARID1B PIK3R1 KAT6A MED12L SMARCA4 TNRC6B ANKRD17 POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 EP300 | 3.49e-05 | 1221 | 28 | 17 | HP:0001999 |
| HumanPheno | Delayed eruption of teeth | 4.61e-05 | 185 | 28 | 7 | HP:0000684 | |
| HumanPheno | Abnormal lip morphology | SCYL2 CITED2 KMT2C ARID1B KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ SEC31A BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 4.79e-05 | 1249 | 28 | 17 | HP:0000159 |
| HumanPheno | Diagnostic behavioral phenotype | KMT2C ARID1B KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ BCOR TBL1XR1 NIPBL EP300 | 5.79e-05 | 747 | 28 | 13 | HP:0025783 |
| HumanPheno | Short phalanx of the 5th toe | 8.71e-05 | 3 | 28 | 2 | HP:0100368 | |
| HumanPheno | Aplasia/Hypoplasia of toe | 8.85e-05 | 140 | 28 | 6 | HP:0001991 | |
| HumanPheno | Cryptorchidism | SCYL2 CITED2 ARID1B NAF1 KAT6A SMARCA4 TNRC6B PAX7 BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 9.19e-05 | 780 | 28 | 13 | HP:0000028 |
| HumanPheno | Language impairment | KMT2C ARID1B ATXN2 PIK3R1 KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS MAPRE2 TBL1XR1 NIPBL EP300 | 1.04e-04 | 1178 | 28 | 16 | HP:0002463 |
| HumanPheno | Posteriorly rotated ears | 1.16e-04 | 470 | 28 | 10 | HP:0000358 | |
| HumanPheno | Abnormality of the frontal hairline | 1.20e-04 | 215 | 28 | 7 | HP:0000599 | |
| HumanPheno | Abnormal internal genitalia | SCYL2 CITED2 KMT2C ARID1B PIK3R1 NAF1 KAT6A SMARCA4 TNRC6B POGZ SEC31A PAX7 GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 1.32e-04 | 1498 | 28 | 18 | HP:0000812 |
| HumanPheno | Abnormal palate morphology | KMT2C SEC24D ARID1B PIK3R1 KAT6A MED12L SMARCA4 ANKRD17 POGZ SEC31A PAX7 BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 1.35e-04 | 1202 | 28 | 16 | HP:0000174 |
| HumanPheno | Abnormal midface morphology | CITED2 KMT2C SEC24D ARID1B PIK3R1 KAT6A ANKRD17 POGZ GNAS BCOR TBL1XR1 EP300 | 1.61e-04 | 704 | 28 | 12 | HP:0000309 |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 1.74e-04 | 4 | 28 | 2 | HP:0010343 | |
| HumanPheno | Broad nasal tip | 1.79e-04 | 159 | 28 | 6 | HP:0000455 | |
| HumanPheno | Inguinal hernia | 1.91e-04 | 312 | 28 | 8 | HP:0000023 | |
| HumanPheno | Micrognathia | SCYL2 SEC24D ARID1B PIK3R1 KAT6A TNRC6B CHD8 POGZ SEC31A PAX7 MAPRE2 NIPBL EP300 | 2.08e-04 | 843 | 28 | 13 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | SCYL2 SEC24D ARID1B PIK3R1 KAT6A TNRC6B CHD8 POGZ SEC31A PAX7 MAPRE2 NIPBL EP300 | 2.14e-04 | 845 | 28 | 13 | HP:0009118 |
| HumanPheno | Abnormality of the philtrum | ARID1B KAT6A MED12L SMARCA4 ANKRD17 CHD8 POGZ BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 2.17e-04 | 726 | 28 | 12 | HP:0000288 |
| HumanPheno | Abnormal eyelid morphology | KMT2C SEC24D ARID1B PIK3R1 KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ SEC31A BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 2.43e-04 | 1408 | 28 | 17 | HP:0000492 |
| HumanPheno | Delayed speech and language development | KMT2C ARID1B PIK3R1 KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS MAPRE2 TBL1XR1 NIPBL EP300 | 2.56e-04 | 1123 | 28 | 15 | HP:0000750 |
| HumanPheno | Abnormal hair morphology | KMT2C ARID1B PIK3R1 NAF1 KAT6A MED12L SMARCA4 ANKRD17 CHD8 POGZ SEC31A GNAS BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 2.82e-04 | 1424 | 28 | 17 | HP:0001595 |
| HumanPheno | Prenatal growth deficiency | CITED2 SEC24D ARID1B PIK3R1 KAT6A SMARCA4 POGZ SEC31A GNAS NIPBL EP300 | 2.83e-04 | 631 | 28 | 11 | HP:0001515 |
| HumanPheno | Intrauterine growth retardation | CITED2 SEC24D ARID1B PIK3R1 KAT6A SMARCA4 POGZ SEC31A GNAS NIPBL EP300 | 2.83e-04 | 631 | 28 | 11 | HP:0001511 |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th toe | 2.88e-04 | 5 | 28 | 2 | HP:0010383 | |
| HumanPheno | Abnormality of the phalanges of the 5th toe | 2.88e-04 | 5 | 28 | 2 | HP:0010342 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | SCYL2 SEC24D ARID1B PIK3R1 KAT6A TNRC6B CHD8 POGZ SEC31A PAX7 BCOR MAPRE2 NIPBL EP300 | 3.19e-04 | 1008 | 28 | 14 | HP:0009122 |
| HumanPheno | Motor delay | KMT2C SEC24D ARID1B KAT6A MED12L TNRC6B ANKRD17 CHD8 POGZ FLRT1 PAX7 BCOR MAPRE2 EP300 | 3.55e-04 | 1018 | 28 | 14 | HP:0001270 |
| HumanPheno | Uplifted earlobe | 3.55e-04 | 26 | 28 | 3 | HP:0009909 | |
| HumanPheno | Perimembranous ventricular septal defect | 3.55e-04 | 26 | 28 | 3 | HP:0011682 | |
| HumanPheno | Downturned corners of mouth | 3.74e-04 | 182 | 28 | 6 | HP:0002714 | |
| HumanPheno | Upper eyelid edema | 4.31e-04 | 6 | 28 | 2 | HP:0012724 | |
| HumanPheno | Prominent interphalangeal joints | 4.31e-04 | 6 | 28 | 2 | HP:0006237 | |
| HumanPheno | Brachydactyly | CITED2 ARID1B PIK3R1 KAT6A SMARCA4 POGZ GNAS BCOR TBL1XR1 NIPBL EP300 | 4.82e-04 | 670 | 28 | 11 | HP:0001156 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | SCYL2 SEC24D ARID1B PIK3R1 KAT6A TNRC6B CHD8 POGZ SEC31A PAX7 MAPRE2 NIPBL EP300 | 4.84e-04 | 915 | 28 | 13 | HP:0009116 |
| HumanPheno | Abnormal external nose morphology | SCYL2 ARID1B PIK3R1 KAT6A MED12L SMARCA4 ANKRD17 POGZ PAX7 BCOR TBL1XR1 NIPBL EP300 | 4.89e-04 | 916 | 28 | 13 | HP:0010938 |
| HumanPheno | Short digit | CITED2 ARID1B PIK3R1 KAT6A SMARCA4 POGZ GNAS BCOR TBL1XR1 NIPBL EP300 | 4.94e-04 | 672 | 28 | 11 | HP:0011927 |
| HumanPheno | Abnormality of the abdominal wall | KMT2C ARID1B PIK3R1 KAT6A TNRC6B POGZ SEC31A BCOR MAPRE2 NIPBL | 4.95e-04 | 560 | 28 | 10 | HP:0004298 |
| HumanPheno | Abnormal eyebrow morphology | KMT2C ARID1B KAT6A MED12L SMARCA4 CHD8 BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 5.07e-04 | 674 | 28 | 11 | HP:0000534 |
| HumanPheno | Long eyelashes | 5.93e-04 | 129 | 28 | 5 | HP:0000527 | |
| HumanPheno | Disinhibition | KMT2C ARID1B MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS BCOR NIPBL EP300 | 5.96e-04 | 807 | 28 | 12 | HP:0000734 |
| HumanPheno | Inappropriate behavior | KMT2C ARID1B MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS BCOR NIPBL EP300 | 5.96e-04 | 807 | 28 | 12 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | KMT2C ARID1B MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS BCOR NIPBL EP300 | 5.96e-04 | 807 | 28 | 12 | HP:5200123 |
| HumanPheno | Social disinhibition | KMT2C ARID1B MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS BCOR NIPBL EP300 | 5.96e-04 | 807 | 28 | 12 | HP:5200029 |
| HumanPheno | Abnormal joint physiology | SCYL2 SEC24D ARID1B PIK3R1 SMARCA4 TNRC6B ANKRD17 POGZ SEC31A FLRT1 PAX7 GNAS BCOR TBL1XR1 NIPBL EP300 | 6.14e-04 | 1358 | 28 | 16 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | SCYL2 SEC24D ARID1B PIK3R1 SMARCA4 TNRC6B ANKRD17 POGZ SEC31A FLRT1 PAX7 GNAS BCOR TBL1XR1 NIPBL EP300 | 6.14e-04 | 1358 | 28 | 16 | HP:0011729 |
| HumanPheno | Abnormal cheek morphology | 6.40e-04 | 282 | 28 | 7 | HP:0004426 | |
| HumanPheno | Aplasia of the toes | 6.45e-04 | 74 | 28 | 4 | HP:0011306 | |
| HumanPheno | Absent toe | 6.45e-04 | 74 | 28 | 4 | HP:0010760 | |
| HumanPheno | Hernia | KMT2C ARID1B PIK3R1 SMARCA4 TNRC6B POGZ SEC31A BCOR MAPRE2 NIPBL | 7.44e-04 | 589 | 28 | 10 | HP:0100790 |
| HumanPheno | Midface retrusion | 7.72e-04 | 291 | 28 | 7 | HP:0011800 | |
| HumanPheno | Abnormal earlobe morphology | 7.81e-04 | 137 | 28 | 5 | HP:0000363 | |
| HumanPheno | Long thorax | 7.99e-04 | 8 | 28 | 2 | HP:0100818 | |
| HumanPheno | Abnormal nasal tip morphology | 8.13e-04 | 386 | 28 | 8 | HP:0000436 | |
| HumanPheno | Abnormality of mouth shape | 8.21e-04 | 294 | 28 | 7 | HP:0011338 | |
| HumanPheno | Abnormality of the hairline | 8.21e-04 | 294 | 28 | 7 | HP:0009553 | |
| HumanPheno | Abnormality of globe location or size | SCYL2 CITED2 SEC24D ARID1B PIK3R1 KAT6A MED12L ANKRD17 CHD8 POGZ BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 8.48e-04 | 1246 | 28 | 15 | HP:0000489 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 8.90e-04 | 298 | 28 | 7 | HP:0006494 | |
| HumanPheno | Hirsutism | 9.32e-04 | 216 | 28 | 6 | HP:0001007 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the toes | 9.41e-04 | 36 | 28 | 3 | HP:0010173 | |
| HumanPheno | Abnormal upper lip morphology | ARID1B KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ BCOR MAPRE2 TBL1XR1 NIPBL EP300 | 9.62e-04 | 980 | 28 | 13 | HP:0000177 |
| HumanPheno | Depressed nasal bridge | SCYL2 ARID1B MED12L SMARCA4 CHD8 POGZ GNAS MAPRE2 NIPBL EP300 | 1.01e-03 | 612 | 28 | 10 | HP:0005280 |
| HumanPheno | Flattened nasal bridge | SCYL2 ARID1B MED12L SMARCA4 CHD8 POGZ GNAS MAPRE2 NIPBL EP300 | 1.01e-03 | 612 | 28 | 10 | HP:0000425 |
| HumanPheno | Abnormality of globe location | SCYL2 CITED2 SEC24D ARID1B PIK3R1 KAT6A MED12L ANKRD17 CHD8 POGZ MAPRE2 TBL1XR1 NIPBL EP300 | 1.01e-03 | 1122 | 28 | 14 | HP:0100886 |
| HumanPheno | Low anterior hairline | 1.07e-03 | 147 | 28 | 5 | HP:0000294 | |
| HumanPheno | Hernia of the abdominal wall | 1.08e-03 | 506 | 28 | 9 | HP:0004299 | |
| HumanPheno | Pneumonia | 1.15e-03 | 311 | 28 | 7 | HP:0002090 | |
| HumanPheno | Abdominal wall defect | 1.15e-03 | 511 | 28 | 9 | HP:0010866 | |
| HumanPheno | Thoracoabdominal wall defect | 1.15e-03 | 511 | 28 | 9 | HP:0100656 | |
| HumanPheno | Abnormally increased volition | KMT2C ARID1B MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS BCOR NIPBL EP300 | 1.18e-03 | 869 | 28 | 12 | HP:5200263 |
| HumanPheno | Bone pain | 1.19e-03 | 87 | 28 | 4 | HP:0002653 | |
| HumanPheno | Thick nasal alae | 1.19e-03 | 39 | 28 | 3 | HP:0009928 | |
| HumanPheno | Abnormal umbilicus morphology | 1.19e-03 | 313 | 28 | 7 | HP:0001551 | |
| HumanPheno | Impairment in personality functioning | KMT2C ARID1B TIA1 ATXN2 MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS BCOR NIPBL EP300 | 1.20e-03 | 1141 | 28 | 14 | HP:0031466 |
| HumanPheno | Aggressive behavior | 1.24e-03 | 516 | 28 | 9 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.24e-03 | 516 | 28 | 9 | HP:0006919 | |
| HumanPheno | Recurrent maladaptive behavior | KMT2C ARID1B ATXN2 KAT6A MED12L SMARCA4 TNRC6B ANKRD17 CHD8 POGZ GNAS BCOR TBL1XR1 NIPBL EP300 | 1.28e-03 | 1293 | 28 | 15 | HP:5200241 |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | SCYL2 NCOA6 LATS1 TIA1 PIK3R1 CECR2 MAZ MAML1 SMARCA4 TNRC6B WWTR1 SSBP2 POGZ PAX7 GNAS NFAT5 NIPBL EP300 | 5.72e-06 | 1124 | 69 | 18 | MP:0011112 |
| MousePheno | perinatal lethality | SCYL2 CITED2 KMT2C NCOA6 NMNAT2 ARID1B LATS1 PIK3R1 CECR2 KAT6A TNRC6B WWTR1 SSBP2 TNRC6C GNAS NFAT5 EP300 | 2.51e-05 | 1130 | 69 | 17 | MP:0002081 |
| MousePheno | postnatal lethality, incomplete penetrance | LATS1 TIA1 PIK3R1 MAZ MAML1 SMARCA4 WWTR1 PAX7 GNAS NFAT5 NIPBL EP300 | 9.38e-05 | 669 | 69 | 12 | MP:0011086 |
| MousePheno | abnormal fetal growth/weight/body size | 1.44e-04 | 312 | 69 | 8 | MP:0004197 | |
| MousePheno | abnormal vocalization | 1.63e-04 | 237 | 69 | 7 | MP:0001529 | |
| MousePheno | abnormal fluid regulation | CITED2 NCOR1 NCOA6 NMNAT2 ARID1B PIK3R1 KAT6A ANKRD17 UNK GNAS NFAT5 EP300 PRRC2B | 1.72e-04 | 826 | 69 | 13 | MP:0001784 |
| MousePheno | small heart | 1.75e-04 | 321 | 69 | 8 | MP:0002188 | |
| MousePheno | lethality throughout fetal growth and development | 2.73e-04 | 435 | 69 | 9 | MP:0006208 | |
| MousePheno | abnormal blood cell morphology/development | SMAP1 NCOR1 NCOA6 CTTNBP2 PIK3R1 KAT6A TNRC6A MAML1 SMARCA4 SSBP2 POGZ NFAT5 ZBTB1 EP300 | 2.74e-04 | 986 | 69 | 14 | MP:0002429 |
| MousePheno | ventricular septal defect | 2.93e-04 | 261 | 69 | 7 | MP:0010402 | |
| MousePheno | embryonic lethality during organogenesis | CITED2 BCL9L NCOA6 SEC24D TNRC6A SMARCA4 ANKRD17 CHD8 POGZ BCOR NIPBL SF1 EP300 | 3.07e-04 | 876 | 69 | 13 | MP:0006207 |
| MousePheno | abnormal myocardium compact layer morphology | 3.30e-04 | 67 | 69 | 4 | MP:0004056 | |
| Domain | Ago_hook | 8.16e-08 | 3 | 82 | 3 | PF10427 | |
| Domain | Neuroggenic_mastermind-like_N | 8.16e-08 | 3 | 82 | 3 | IPR019082 | |
| Domain | TNRC6_PABC-bd | 8.16e-08 | 3 | 82 | 3 | IPR032226 | |
| Domain | Argonaute_hook_dom | 8.16e-08 | 3 | 82 | 3 | IPR019486 | |
| Domain | MamL-1 | 8.16e-08 | 3 | 82 | 3 | PF09596 | |
| Domain | TNRC6-PABC_bdg | 8.16e-08 | 3 | 82 | 3 | PF16608 | |
| Domain | MamL-1 | 8.16e-08 | 3 | 82 | 3 | SM01275 | |
| Domain | BCL9_beta-catenin-bd_dom | 1.90e-05 | 2 | 82 | 2 | IPR024670 | |
| Domain | BCL9 | 1.90e-05 | 2 | 82 | 2 | PF11502 | |
| Domain | M_domain | 1.90e-05 | 2 | 82 | 2 | PF12938 | |
| Domain | GW182_M_dom | 1.90e-05 | 2 | 82 | 2 | IPR026805 | |
| Domain | Bcl-9 | 1.90e-05 | 2 | 82 | 2 | IPR015668 | |
| Domain | UBA-like | 1.79e-04 | 64 | 82 | 4 | IPR009060 | |
| Domain | Bromodomain_CS | 1.97e-04 | 26 | 82 | 3 | IPR018359 | |
| Domain | BRK | 2.82e-04 | 6 | 82 | 2 | SM00592 | |
| Domain | BRK_domain | 2.82e-04 | 6 | 82 | 2 | IPR006576 | |
| Domain | BRK | 2.82e-04 | 6 | 82 | 2 | PF07533 | |
| Domain | BROMODOMAIN_1 | 5.69e-04 | 37 | 82 | 3 | PS00633 | |
| Domain | Bromodomain | 6.16e-04 | 38 | 82 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 7.71e-04 | 41 | 82 | 3 | PS50014 | |
| Domain | BROMO | 8.28e-04 | 42 | 82 | 3 | SM00297 | |
| Domain | Bromodomain | 8.28e-04 | 42 | 82 | 3 | IPR001487 | |
| Domain | - | 8.28e-04 | 42 | 82 | 3 | 1.20.920.10 | |
| Domain | AT_hook | 2.20e-03 | 16 | 82 | 2 | PF02178 | |
| Domain | Ank | 3.30e-03 | 228 | 82 | 5 | PF00023 | |
| Domain | RRM | 3.43e-03 | 230 | 82 | 5 | PS50102 | |
| Domain | zf-CCHC | 4.54e-03 | 23 | 82 | 2 | PF00098 | |
| Domain | - | 4.72e-03 | 248 | 82 | 5 | 1.25.40.20 | |
| Domain | ANK | 4.96e-03 | 251 | 82 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 5.13e-03 | 253 | 82 | 5 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 5.21e-03 | 254 | 82 | 5 | IPR020683 | |
| Domain | ANK_REP_REGION | 5.21e-03 | 254 | 82 | 5 | PS50297 | |
| Domain | Nucleotide-bd_a/b_plait | 5.56e-03 | 258 | 82 | 5 | IPR012677 | |
| Domain | - | 5.78e-03 | 26 | 82 | 2 | 4.10.60.10 | |
| Domain | SANT_dom | 5.78e-03 | 26 | 82 | 2 | IPR017884 | |
| Domain | Ankyrin_rpt | 5.93e-03 | 262 | 82 | 5 | IPR002110 | |
| Domain | LisH | 6.68e-03 | 28 | 82 | 2 | SM00667 | |
| Domain | SANT | 6.68e-03 | 28 | 82 | 2 | PS51293 | |
| Domain | LisH | 6.68e-03 | 28 | 82 | 2 | IPR006594 | |
| Domain | LISH | 6.68e-03 | 28 | 82 | 2 | PS50896 | |
| Domain | HMGI/Y_DNA-bd_CS | 8.15e-03 | 31 | 82 | 2 | IPR000637 | |
| Domain | SNF2_N | 8.67e-03 | 32 | 82 | 2 | IPR000330 | |
| Domain | SNF2_N | 8.67e-03 | 32 | 82 | 2 | PF00176 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 4.49e-09 | 37 | 53 | 6 | M29790 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.01e-08 | 47 | 53 | 6 | M29777 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.29e-08 | 48 | 53 | 6 | M611 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.68e-08 | 10 | 53 | 4 | MM15535 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.70e-08 | 28 | 53 | 5 | M6177 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 7.35e-08 | 58 | 53 | 6 | M29616 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.62e-08 | 12 | 53 | 4 | M27159 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.00e-07 | 61 | 53 | 6 | M39540 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.15e-07 | 32 | 53 | 5 | M27900 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.47e-07 | 65 | 53 | 6 | M39682 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.73e-07 | 14 | 53 | 4 | M27808 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.86e-07 | 119 | 53 | 7 | M607 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.94e-07 | 246 | 53 | 9 | M10189 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.13e-07 | 16 | 53 | 4 | M27121 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.21e-07 | 74 | 53 | 6 | M616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 5.24e-07 | 18 | 53 | 4 | MM14775 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 5.94e-07 | 82 | 53 | 6 | MM15922 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.25e-07 | 20 | 53 | 4 | M27881 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.50e-06 | 23 | 53 | 4 | MM14954 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.74e-06 | 7 | 53 | 3 | M46421 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.12e-06 | 25 | 53 | 4 | M27880 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.21e-06 | 161 | 53 | 7 | M27871 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.50e-06 | 26 | 53 | 4 | MM14793 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 3.41e-06 | 28 | 53 | 4 | M48253 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 3.69e-06 | 63 | 53 | 5 | M27862 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.94e-06 | 29 | 53 | 4 | M48076 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 4.15e-06 | 9 | 53 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 4.15e-06 | 9 | 53 | 3 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 5.91e-06 | 10 | 53 | 3 | M48013 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 6.72e-06 | 33 | 53 | 4 | M604 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | CITED2 NCOR1 KMT2C ARID1B MED8 KAT6A TNRC6A RBM14 MAML1 SMARCA4 TNRC6B WWTR1 MAML2 TNRC6C TBL1XR1 MAML3 EP300 | 7.11e-06 | 1387 | 53 | 17 | M734 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 7.24e-06 | 272 | 53 | 8 | M29619 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.08e-05 | 12 | 53 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.08e-05 | 12 | 53 | 3 | M47533 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOR1 KMT2C NCOA6 ARID1B PIK3R1 MED8 TNRC6A MAML1 SMARCA4 TNRC6B WWTR1 MAML2 PAX7 TNRC6C TBL1XR1 MAML3 EP300 | 1.09e-05 | 1432 | 53 | 17 | M509 |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.20e-05 | 80 | 53 | 5 | M223 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.33e-05 | 39 | 53 | 4 | MM14604 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.40e-05 | 13 | 53 | 3 | M47534 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 1.40e-05 | 13 | 53 | 3 | M46434 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.53e-05 | 84 | 53 | 5 | M1008 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.79e-05 | 42 | 53 | 4 | M17541 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.77e-05 | 237 | 53 | 7 | M27786 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 2.78e-05 | 95 | 53 | 5 | M48268 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.82e-05 | 47 | 53 | 4 | M7946 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.92e-05 | 96 | 53 | 5 | M27792 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.92e-05 | 96 | 53 | 5 | M27784 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.93e-05 | 330 | 53 | 8 | M7847 | |
| Pathway | PID_HES_HEY_PATHWAY | 3.07e-05 | 48 | 53 | 4 | M288 | |
| Pathway | WP_RETT_SYNDROME | 3.07e-05 | 48 | 53 | 4 | M39759 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 3.29e-05 | 17 | 53 | 3 | M27788 | |
| Pathway | REACTOME_HEME_SIGNALING | 3.33e-05 | 49 | 53 | 4 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 3.33e-05 | 49 | 53 | 4 | M48250 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.33e-05 | 49 | 53 | 4 | M618 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.93e-05 | 18 | 53 | 3 | M26942 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 4.22e-05 | 52 | 53 | 4 | M2404 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 4.66e-05 | 19 | 53 | 3 | M48238 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 5.13e-05 | 464 | 53 | 9 | M27547 | |
| Pathway | REACTOME_ADIPOGENESIS | 5.62e-05 | 110 | 53 | 5 | M48259 | |
| Pathway | PID_NOTCH_PATHWAY | 6.95e-05 | 59 | 53 | 4 | M17 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.35e-05 | 22 | 53 | 3 | MM1370 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 7.86e-05 | 118 | 53 | 5 | M27316 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 9.61e-05 | 24 | 53 | 3 | M13404 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.13e-04 | 296 | 53 | 7 | M27869 | |
| Pathway | REACTOME_GASTRULATION | 1.20e-04 | 129 | 53 | 5 | M46433 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.28e-04 | 69 | 53 | 4 | M46439 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.36e-04 | 70 | 53 | 4 | M938 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.38e-04 | 27 | 53 | 3 | M39545 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.59e-04 | 137 | 53 | 5 | M48232 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.87e-04 | 76 | 53 | 4 | MM15520 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 2.06e-04 | 6 | 53 | 2 | MM15083 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.06e-04 | 6 | 53 | 2 | MM14521 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 2.30e-04 | 32 | 53 | 3 | M48012 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 2.51e-04 | 82 | 53 | 4 | M594 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 2.77e-04 | 34 | 53 | 3 | M46422 | |
| Pathway | REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX | 2.88e-04 | 7 | 53 | 2 | M27899 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 3.02e-04 | 35 | 53 | 3 | M27190 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 3.02e-04 | 35 | 53 | 3 | M47969 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 3.09e-04 | 158 | 53 | 5 | MM14791 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | CITED2 KAT6A TNRC6A RBM14 MAML1 SMARCA4 TNRC6B WWTR1 MAML2 TBL1XR1 MAML3 EP300 | 3.27e-04 | 1022 | 53 | 12 | MM15436 |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.56e-04 | 37 | 53 | 3 | M27797 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 3.64e-04 | 254 | 53 | 6 | M27131 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.74e-04 | 91 | 53 | 4 | M27101 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.23e-04 | 94 | 53 | 4 | M1041 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 4.84e-04 | 41 | 53 | 3 | M29748 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | CITED2 KAT6A RBM14 MAML1 SMARCA4 WWTR1 MAML2 TBL1XR1 MAML3 EP300 | 5.01e-04 | 768 | 53 | 10 | MM14851 |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 5.19e-04 | 42 | 53 | 3 | M27272 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 7.46e-04 | 11 | 53 | 2 | M26924 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.46e-04 | 11 | 53 | 2 | MM15510 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 8.94e-04 | 12 | 53 | 2 | M27765 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION | 8.94e-04 | 12 | 53 | 2 | M47770 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | CITED2 NCOR1 NCOA6 TNRC6A TNRC6B SEC31A TNRC6C TBL1XR1 EP300 SH3BP4 | 8.99e-04 | 828 | 53 | 10 | M27827 |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 9.20e-04 | 51 | 53 | 3 | M665 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME | 1.05e-03 | 13 | 53 | 2 | M29766 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.05e-03 | 13 | 53 | 2 | MM15622 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.13e-03 | 122 | 53 | 4 | M29689 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.15e-03 | 55 | 53 | 3 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.15e-03 | 55 | 53 | 3 | M27001 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.34e-03 | 58 | 53 | 3 | M11980 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.38e-03 | 220 | 53 | 5 | M27794 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 1.41e-03 | 15 | 53 | 2 | MM14536 | |
| Pubmed | BCL9L NCOR1 KMT2C NCOA6 ARID1B ATXN2 ZMIZ2 MAZ MED8 WDR20 NFRKB TNRC6A MAML1 SMARCA4 TNRC6B ANKRD17 UNK CHD8 SSBP2 POGZ PAX7 TNRC6C R3HDM1 BCL9 BCOR MIDEAS TBL1XR1 SAP130 ZBTB1 NIPBL EP300 PRRC2B ZNF687 | 4.05e-24 | 1429 | 84 | 33 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOR1 KMT2C NCOA6 ARID1B ZMIZ2 NFRKB MAML1 SMARCA4 CHD8 SSBP2 POGZ BCL9 BCOR MIDEAS TBL1XR1 NIPBL EP300 PRRC2B | 1.33e-20 | 351 | 84 | 19 | 38297188 |
| Pubmed | BCL9L NCOR1 NCOA6 ARID1B MED8 NFRKB MAML1 SMARCA4 CHD8 SSBP2 BCL9 BCOR MIDEAS TBL1XR1 SAP130 NIPBL PRRC2B | 1.15e-19 | 268 | 84 | 17 | 33640491 | |
| Pubmed | ZMIZ2 HDX TNRC6A RBM14 MAML1 TNRC6B TNRC6C R3HDM1 BCL9 BCOR MIDEAS SF1 EP300 PRRC2B | 1.23e-18 | 152 | 84 | 14 | 38360978 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOR1 KMT2C NCOA6 ARID1B ATXN2 TNRC6A RBM14 MAML1 TNRC6B ANKRD17 WWTR1 BCL9 BCOR MIDEAS SAP130 MAML3 EP300 PRRC2B | 1.86e-18 | 457 | 84 | 19 | 32344865 |
| Pubmed | NCOR1 KMT2C NCOA6 ARID1B DDX17 ATXN2 ZMIZ2 MED8 NFRKB RBM14 MAML1 SMARCA4 CHD8 POGZ BCL9 BCOR MIDEAS TBL1XR1 SAP130 NIPBL SF1 EP300 PRRC2B ZNF687 | 8.79e-17 | 1103 | 84 | 24 | 34189442 | |
| Pubmed | NCOR1 NCOA6 ARID1B SMARCA4 POGZ BCL9 BCOR MIDEAS SAP130 NIPBL EP300 | 1.16e-16 | 83 | 84 | 11 | 28794006 | |
| Pubmed | SCYL2 NCOR1 KMT2C NCOA6 ARID1B LATS1 MED8 NFRKB SMARCA4 TNRC6B CHD8 WWTR1 POGZ BCOR MIDEAS SAP130 EP300 PRRC2B | 1.02e-15 | 549 | 84 | 18 | 38280479 | |
| Pubmed | KMT2C NCOA6 NMNAT2 ARID1B CECR2 CAPRIN2 TNRC6A MAML1 MED12L ANKRD17 UNK CHD8 POGZ MAML2 BCOR ZNF687 | 1.62e-13 | 529 | 84 | 16 | 14621295 | |
| Pubmed | ARID1B PIK3R1 CECR2 MAZ NAF1 WDR20 KAT6A CAPRIN2 NFRKB TNRC6A SMARCA4 TNRC6B ANKRD17 CHD8 POGZ BCOR SAP130 EP300 PRRC2B ZNF687 | 1.74e-12 | 1116 | 84 | 20 | 31753913 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.13e-11 | 180 | 84 | 10 | 35198878 | |
| Pubmed | BCL9L NCOR1 NCOA6 DDX17 CECR2 MAZ MED8 NFRKB MAML1 R3HDM1 BCL9 NIPBL EP300 | 3.22e-11 | 425 | 84 | 13 | 24999758 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOR1 NCOA6 LATS1 ATXN2 PIK3R1 ZMIZ2 UNK MAML2 PAX7 BCL9 SAP130 SH3BP4 TMEM139 | 3.72e-11 | 430 | 84 | 13 | 35044719 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | KMT2C ARID1B CECR2 ZMIZ2 MAZ NFRKB RBM14 MAML1 SMARCA4 POGZ BCOR EP300 | 2.30e-10 | 398 | 84 | 12 | 35016035 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOR1 NCOA6 LATS1 NAF1 NFRKB RBM14 SMARCA4 ANKRD17 UNK POGZ BCL9 BCOR NIPBL SF1 ZNF687 | 5.08e-10 | 774 | 84 | 15 | 15302935 |
| Pubmed | 8.54e-10 | 78 | 84 | 7 | 28611094 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOR1 NCOA6 ARID1B DDX17 ATXN2 MAZ NFRKB RBM14 SMARCA4 CHD8 POGZ BCOR MIDEAS SAP130 NIPBL SF1 | 1.01e-09 | 954 | 84 | 16 | 36373674 |
| Pubmed | NCOR1 CTTNBP2 ATXN2 TMEM259 KIAA1217 SMARCA4 TNRC6B ANKRD17 CHD8 SEC31A BCL9 BCOR TBL1XR1 ZBTB1 NIPBL PRRC2B | 1.16e-09 | 963 | 84 | 16 | 28671696 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOR1 KMT2C NCOA6 DDX17 MAZ NFRKB RBM14 SMARCA4 WWTR1 POGZ BCOR MIDEAS TBL1XR1 SAP130 NIPBL SF1 EP300 ZNF687 | 1.54e-09 | 1294 | 84 | 18 | 30804502 |
| Pubmed | KMT2C LATS1 PIK3R1 TNRC6A ANKRD17 CHD8 WWTR1 POGZ SEC31A MIDEAS EP300 SH3BP4 | 2.20e-09 | 486 | 84 | 12 | 20936779 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.65e-09 | 146 | 84 | 8 | 23892456 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.36e-09 | 220 | 84 | 9 | 35785414 | |
| Pubmed | NCOR1 NCOA6 ARID1B MED8 MAML1 ANKRD17 BCL9 BCOR NIPBL MAML3 EP300 PRRC2B ZNF687 | 4.48e-09 | 638 | 84 | 13 | 31182584 | |
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 12386158 | ||
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 1.36e-08 | 3 | 84 | 3 | 34108231 | |
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 16880270 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 31670606 | ||
| Pubmed | SCYL2 SMAP1 NCOA6 ARID1B TNRC6B CHD8 SEC31A MIDEAS MAPRE2 SAP130 ZNF687 | 1.95e-08 | 472 | 84 | 11 | 38943005 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SCYL2 SMAP1 SEC24D DDX17 KIAA1217 NAF1 WDR20 MAML1 POGZ SEC31A TNRC6C GNAS R3HDM1 TBL1XR1 ZBTB1 | 2.60e-08 | 1038 | 84 | 15 | 26673895 |
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 5.43e-08 | 4 | 84 | 3 | 21063388 | |
| Pubmed | MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis. | 5.43e-08 | 4 | 84 | 3 | 32482852 | |
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 20181956 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOR1 KMT2C NCOA6 VOPP1 TMEM259 ZMIZ2 KAT6A MAML1 CHD8 TNRC6C BCL9 EP300 PRRC2B ZNF687 SH3BP4 | 5.89e-08 | 1105 | 84 | 15 | 35748872 |
| Pubmed | NCOR1 ZMIZ2 TNRC6A TNRC6B ANKRD17 CHD8 POGZ BCOR ZBTB1 ZNF687 | 7.07e-08 | 418 | 84 | 10 | 34709266 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 8.27e-08 | 150 | 84 | 7 | 28242625 | |
| Pubmed | BCL9L KMT2C ATXN2 MAZ MED8 WDR20 NFRKB TNRC6A MAML1 TNRC6B ANKRD17 UNK CHD8 BCOR TBL1XR1 NIPBL ZNF687 | 9.04e-08 | 1497 | 84 | 17 | 31527615 | |
| Pubmed | 1.16e-07 | 332 | 84 | 9 | 37433992 | ||
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 1.28e-07 | 336 | 84 | 9 | 31253590 | |
| Pubmed | 1.38e-07 | 339 | 84 | 9 | 30415952 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.45e-07 | 341 | 84 | 9 | 32971831 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2 MAZ TNRC6A RBM14 TNRC6B ANKRD17 UNK POGZ SEC31A R3HDM1 SF1 PRRC2B | 1.74e-07 | 724 | 84 | 12 | 36232890 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | DDX17 TIA1 ATXN2 NAF1 TNRC6A RBM14 TNRC6B ANKRD17 UNK PRRC2B | 1.78e-07 | 462 | 84 | 10 | 31138677 |
| Pubmed | 2.24e-07 | 22 | 84 | 4 | 22187428 | ||
| Pubmed | NCOR1 ATXN2 USHBP1 KAT6A RBM14 TNRC6B UNK R3HDM1 BCOR PRRC2B PDZD4 | 2.50e-07 | 608 | 84 | 11 | 16713569 | |
| Pubmed | 2.55e-07 | 263 | 84 | 8 | 34702444 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 11443112 | ||
| Pubmed | 2.76e-07 | 57 | 84 | 5 | 21122108 | ||
| Pubmed | SMAP1 ARID1B DDX17 ATXN2 RBM14 SMARCA4 ANKRD17 TSPYL5 GNAS MIDEAS PRRC2B | 2.80e-07 | 615 | 84 | 11 | 31048545 | |
| Pubmed | SMAP1 NCOR1 SEC24D DDX17 WDR20 TNRC6A RBM14 MAML1 TNRC6B SEC31A PRRC2B SH3BP4 | 3.69e-07 | 777 | 84 | 12 | 35844135 | |
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 4.72e-07 | 7 | 84 | 3 | 19470757 | |
| Pubmed | 4.72e-07 | 7 | 84 | 3 | 19383768 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KMT2C NMNAT2 ATXN2 KIAA1217 KAT6A TNRC6B ANKRD17 TNRC6C GNAS NFAT5 IMMP2L TBL1XR1 SAP130 MAML3 EP300 SH3BP4 | 4.79e-07 | 1489 | 84 | 16 | 28611215 |
| Pubmed | 7.43e-07 | 129 | 84 | 6 | 23022380 | ||
| Pubmed | SCYL2 SMAP1 LATS1 ATXN2 MAZ MED8 RBM14 TNRC6B UNK SEC31A R3HDM1 BCL9 PRRC2B | 8.71e-07 | 1007 | 84 | 13 | 34597346 | |
| Pubmed | CITED2 KMT2C ZMIZ2 SMARCA4 POGZ PAX7 NFAT5 ZBTB1 MAML3 SF1 ZNF687 | 1.13e-06 | 709 | 84 | 11 | 22988430 | |
| Pubmed | 1.13e-06 | 9 | 84 | 3 | 12370315 | ||
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 1.13e-06 | 9 | 84 | 3 | 27325115 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.31e-06 | 444 | 84 | 9 | 34795231 | |
| Pubmed | 1.39e-06 | 34 | 84 | 4 | 30894540 | ||
| Pubmed | ARID1B MTMR4 NFRKB TNRC6A MAML1 SMARCA4 TNRC6B UNK R3HDM1 MAPRE2 ZNF687 | 1.56e-06 | 733 | 84 | 11 | 34672954 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOR1 KIAA1217 TNRC6A RBM14 MAML1 UNK GNAS ZCCHC2 BCOR PRRC2B | 1.59e-06 | 588 | 84 | 10 | 38580884 |
| Pubmed | 1.61e-06 | 10 | 84 | 3 | 12738788 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ARID1B DDX17 CECR2 MAZ RBM14 SMARCA4 TNRC6B TSPYL5 SSBP2 POGZ SEC31A NIPBL SF1 | 1.93e-06 | 1082 | 84 | 13 | 38697112 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.14e-06 | 608 | 84 | 10 | 36089195 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.28e-06 | 475 | 84 | 9 | 31040226 | |
| Pubmed | 2.34e-06 | 157 | 84 | 6 | 30186101 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SCYL2 DDX17 KIAA1217 NAF1 SMARCA4 TNRC6B ANKRD17 BCOR MAPRE2 NIPBL SF1 PRRC2B | 2.51e-06 | 934 | 84 | 12 | 33916271 |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.71e-06 | 40 | 84 | 4 | 34585037 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 3.17e-06 | 258 | 84 | 7 | 37794589 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 3.34e-06 | 167 | 84 | 6 | 20362541 | |
| Pubmed | 3.82e-06 | 13 | 84 | 3 | 16469706 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DDX17 TIA1 ATXN2 MAZ NAF1 TNRC6A RBM14 UNK R3HDM1 SF1 PRRC2B | 3.91e-06 | 807 | 84 | 11 | 22681889 |
| Pubmed | DDX17 TNRC6A RBM14 TNRC6B ANKRD17 TSPYL5 GNAS MIDEAS SAP130 PRRC2B | 4.14e-06 | 655 | 84 | 10 | 35819319 | |
| Pubmed | 4.78e-06 | 46 | 84 | 4 | 20301533 | ||
| Pubmed | Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. | 4.85e-06 | 14 | 84 | 3 | 19716330 | |
| Pubmed | 5.05e-06 | 102 | 84 | 5 | 11214970 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29791863 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 37909960 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26036967 | ||
| Pubmed | Lifelong restructuring of 3D genome architecture in cerebellar granule cells. | 5.76e-06 | 2 | 84 | 2 | 37676945 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 38811552 | ||
| Pubmed | TAZ suppresses NFAT5 activity through tyrosine phosphorylation. | 5.76e-06 | 2 | 84 | 2 | 23045390 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15371335 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 28625977 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29787761 | ||
| Pubmed | MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). | 5.76e-06 | 2 | 84 | 2 | 10824998 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20682801 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33767438 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 28867767 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 5.82e-06 | 283 | 84 | 7 | 28533407 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 5.83e-06 | 184 | 84 | 6 | 32908313 | |
| Pubmed | 6.06e-06 | 15 | 84 | 3 | 19762545 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 6.06e-06 | 15 | 84 | 3 | 21981923 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 MTMR4 LATS1 KIAA1217 MAZ RBM14 ANKRD17 WWTR1 GNAS R3HDM1 SH3BP4 | 7.20e-06 | 861 | 84 | 11 | 36931259 |
| Pubmed | 7.44e-06 | 16 | 84 | 3 | 23870121 | ||
| Pubmed | Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. | 7.44e-06 | 16 | 84 | 3 | 22069191 | |
| Pubmed | NCOR1 NCOA6 LATS1 DDX17 PIK3R1 MED8 TNRC6B ANKRD17 GNAS NFAT5 TBL1XR1 SF1 SH3BP4 | 8.95e-06 | 1247 | 84 | 13 | 27684187 | |
| Pubmed | 9.02e-06 | 17 | 84 | 3 | 19183483 | ||
| Pubmed | 9.47e-06 | 116 | 84 | 5 | 30804394 | ||
| Pubmed | 1.08e-05 | 18 | 84 | 3 | 24740910 | ||
| Interaction | TBXT interactions | NCOR1 KMT2C NCOA6 ARID1B MED8 MAML1 SMARCA4 SSBP2 POGZ BCL9 BCOR MIDEAS SAP130 NIPBL EP300 | 8.70e-19 | 116 | 83 | 15 | int:TBXT |
| Interaction | EGR2 interactions | BCL9L NCOR1 KMT2C NCOA6 ARID1B ZMIZ2 NFRKB MAML1 SSBP2 POGZ BCL9 BCOR MIDEAS NIPBL EP300 PRRC2B | 1.12e-17 | 171 | 83 | 16 | int:EGR2 |
| Interaction | AR interactions | BCL9L NCOR1 KMT2C NCOA6 ARID1B DDX17 PIK3R1 KIAA1217 ZMIZ2 MED8 WDR20 NFRKB RBM14 MAML1 MED12L SMARCA4 CHD8 SSBP2 GNAS BCL9 BCOR MIDEAS TBL1XR1 SAP130 ZBTB1 NIPBL EP300 PRRC2B | 1.26e-16 | 992 | 83 | 28 | int:AR |
| Interaction | SMG7 interactions | NCOR1 NCOA6 ARID1B MTMR4 LATS1 ATXN2 TNRC6A MAML1 TNRC6B ANKRD17 UNK CHD8 WWTR1 TNRC6C R3HDM1 BCL9 BCOR PRRC2B | 7.11e-16 | 319 | 83 | 18 | int:SMG7 |
| Interaction | TLE3 interactions | BCL9L NCOR1 ARID1B DDX17 CECR2 ZMIZ2 NFRKB TNRC6A RBM14 MAML1 SMARCA4 PAX7 BCL9 BCOR MIDEAS ANKRD40 SAP130 NIPBL EP300 | 7.66e-16 | 376 | 83 | 19 | int:TLE3 |
| Interaction | SP7 interactions | BCL9L NCOR1 KMT2C NCOA6 ARID1B ZMIZ2 MAML1 SMARCA4 POGZ BCL9 BCOR MIDEAS TBL1XR1 SAP130 NIPBL EP300 PRRC2B | 5.76e-15 | 304 | 83 | 17 | int:SP7 |
| Interaction | PAX9 interactions | BCL9L NCOR1 KMT2C NCOA6 ARID1B ZMIZ2 MAML1 BCL9 BCOR MIDEAS SAP130 NIPBL EP300 | 6.55e-15 | 130 | 83 | 13 | int:PAX9 |
| Interaction | NUP35 interactions | BCL9L NCOR1 KMT2C NCOA6 ARID1B ATXN2 TNRC6A RBM14 MAML1 TNRC6B ANKRD17 WWTR1 BCL9 BCOR MIDEAS SAP130 MAML3 EP300 PRRC2B | 6.84e-15 | 424 | 83 | 19 | int:NUP35 |
| Interaction | ALG13 interactions | NCOR1 ARID1B LATS1 TIA1 ATXN2 TNRC6A TNRC6B UNK R3HDM1 BCL9 BCOR SF1 EP300 PRRC2B | 2.40e-14 | 183 | 83 | 14 | int:ALG13 |
| Interaction | HNF1B interactions | NCOR1 KMT2C ARID1B NFRKB MAML1 POGZ PAX7 BCL9 BCOR MIDEAS SAP130 NIPBL EP300 PRRC2B | 4.05e-14 | 190 | 83 | 14 | int:HNF1B |
| Interaction | GATA2 interactions | NCOR1 KMT2C NCOA6 ARID1B SMARCA4 SSBP2 BCL9 BCOR MIDEAS TBL1XR1 SAP130 NIPBL EP300 PRRC2B | 7.69e-14 | 199 | 83 | 14 | int:GATA2 |
| Interaction | TLX1 interactions | NCOR1 KMT2C ARID1B KAT6A MAML1 SSBP2 POGZ BCL9 BCOR MIDEAS SAP130 NIPBL EP300 | 3.18e-13 | 175 | 83 | 13 | int:TLX1 |
| Interaction | EYA4 interactions | ZMIZ2 HDX TNRC6A RBM14 MAML1 TNRC6B TNRC6C R3HDM1 BCL9 BCOR MIDEAS SF1 EP300 PRRC2B | 1.19e-12 | 243 | 83 | 14 | int:EYA4 |
| Interaction | FEV interactions | NCOR1 KMT2C NCOA6 ARID1B NFRKB MAML1 POGZ BCL9 BCOR MIDEAS NIPBL EP300 PRRC2B | 2.13e-12 | 203 | 83 | 13 | int:FEV |
| Interaction | TLX3 interactions | BCL9L NCOR1 KMT2C NCOA6 ARID1B ZMIZ2 MAML1 POGZ BCL9 BCOR MIDEAS TBL1XR1 NIPBL EP300 | 1.36e-11 | 291 | 83 | 14 | int:TLX3 |
| Interaction | PAX6 interactions | NCOR1 KMT2C NCOA6 ARID1B USHBP1 NFRKB SMARCA4 POGZ BCL9 BCOR MIDEAS SAP130 NIPBL EP300 PRRC2B | 2.30e-11 | 366 | 83 | 15 | int:PAX6 |
| Interaction | KLF5 interactions | NCOR1 KMT2C NCOA6 ARID1B MAZ MAML1 WWTR1 BCL9 BCOR NIPBL EP300 PRRC2B | 2.55e-11 | 195 | 83 | 12 | int:KLF5 |
| Interaction | PAX8 interactions | NCOR1 KMT2C ARID1B MAML1 BCL9 BCOR MIDEAS NIPBL EP300 PRRC2B | 2.96e-11 | 111 | 83 | 10 | int:PAX8 |
| Interaction | TBR1 interactions | 3.54e-11 | 113 | 83 | 10 | int:TBR1 | |
| Interaction | CRX interactions | BCL9L SMAP1 KMT2C ARID1B ZMIZ2 NFRKB MAML1 POGZ BCL9 MIDEAS NIPBL EP300 PRRC2B | 3.60e-11 | 254 | 83 | 13 | int:CRX |
| Interaction | SOX2 interactions | SCYL2 BCL9L NCOR1 KMT2C NCOA6 ARID1B DDX17 TIA1 KIAA1217 ZMIZ2 TNRC6A RBM14 MAML1 SMARCA4 ANKRD17 CHD8 POGZ BCL9 BCOR MIDEAS TBL1XR1 SAP130 NIPBL EP300 PRRC2B ZNF687 | 4.41e-11 | 1422 | 83 | 26 | int:SOX2 |
| Interaction | SOX7 interactions | 5.01e-11 | 82 | 83 | 9 | int:SOX7 | |
| Interaction | FMR1 interactions | NCOR1 TIA1 ATXN2 CECR2 KIAA1217 KAT6A RBM14 SMARCA4 TNRC6B ANKRD17 UNK R3HDM1 BCL9 TBL1XR1 ZBTB1 NIPBL PRRC2B | 5.21e-11 | 536 | 83 | 17 | int:FMR1 |
| Interaction | EWSR1 interactions | BCL9L NCOR1 NCOA6 SEC24D DDX17 TIA1 CECR2 TEDC2 MAZ MED8 KAT6A NFRKB MAML1 SMARCA4 SSBP2 R3HDM1 BCL9 ZBTB1 NIPBL SF1 EP300 | 7.06e-11 | 906 | 83 | 21 | int:EWSR1 |
| Interaction | PAX7 interactions | 8.96e-11 | 124 | 83 | 10 | int:PAX7 | |
| Interaction | HNF4A interactions | NCOR1 KMT2C NCOA6 ARID1B MED8 NFRKB SMARCA4 POGZ BCOR MIDEAS SAP130 NIPBL EP300 | 9.68e-11 | 275 | 83 | 13 | int:HNF4A |
| Interaction | CEBPA interactions | NCOR1 KMT2C NCOA6 ARID1B DDX17 ATXN2 ZMIZ2 MED8 NFRKB RBM14 MAML1 SMARCA4 CHD8 POGZ BCL9 BCOR MIDEAS TBL1XR1 SAP130 NIPBL SF1 EP300 PRRC2B ZNF687 | 1.04e-10 | 1245 | 83 | 24 | int:CEBPA |
| Interaction | ERG interactions | NCOR1 KMT2C NCOA6 ARID1B MAML1 SMARCA4 BCL9 BCOR MIDEAS NIPBL EP300 PRRC2B | 1.22e-10 | 223 | 83 | 12 | int:ERG |
| Interaction | LHX2 interactions | CITED2 BCL9L NCOR1 KMT2C ARID1B SMARCA4 SSBP2 POGZ BCL9 BCOR ZNF687 | 2.34e-10 | 183 | 83 | 11 | int:LHX2 |
| Interaction | FUBP3 interactions | TIA1 ATXN2 TNRC6A RBM14 TNRC6B ANKRD17 UNK TNRC6C R3HDM1 BCOR SF1 EP300 PRRC2B | 2.50e-10 | 297 | 83 | 13 | int:FUBP3 |
| Interaction | UBAP2L interactions | ATXN2 TEDC2 TNRC6A MTNR1A TNRC6B ANKRD17 UNK TNRC6C ZCCHC2 R3HDM1 BCOR IMMP2L PRRC2B | 2.61e-10 | 298 | 83 | 13 | int:UBAP2L |
| Interaction | LHX3 interactions | CITED2 NCOR1 KMT2C ARID1B NFRKB SSBP2 POGZ BCL9 BCOR MIDEAS NIPBL | 2.63e-10 | 185 | 83 | 11 | int:LHX3 |
| Interaction | NFIB interactions | 3.44e-10 | 142 | 83 | 10 | int:NFIB | |
| Interaction | YAP1 interactions | BCL9L NCOR1 KMT2C NCOA6 ARID1B LATS1 DDX17 MED8 NFRKB RBM14 SMARCA4 TNRC6B UNK CHD8 WWTR1 POGZ GNAS MIDEAS NFAT5 SAP130 EP300 TMEM139 | 3.47e-10 | 1095 | 83 | 22 | int:YAP1 |
| Interaction | GCM1 interactions | 3.55e-10 | 68 | 83 | 8 | int:GCM1 | |
| Interaction | MYOD1 interactions | NCOR1 KMT2C ARID1B MED8 SMARCA4 PAX7 BCL9 BCOR MIDEAS NIPBL EP300 | 4.37e-10 | 194 | 83 | 11 | int:MYOD1 |
| Interaction | FOS interactions | NCOR1 KMT2C NCOA6 ARID1B DDX17 PIK3R1 MAZ MED8 SMARCA4 ANKRD17 BCL9 NFAT5 EP300 | 4.58e-10 | 312 | 83 | 13 | int:FOS |
| Interaction | NANOG interactions | NCOR1 KMT2C ARID1B TIA1 CECR2 KIAA1217 HDX RBM14 SMARCA4 POGZ BCOR MIDEAS TBL1XR1 SAP130 EP300 | 1.03e-09 | 481 | 83 | 15 | int:NANOG |
| Interaction | LHX4 interactions | BCL9L NCOR1 KMT2C ARID1B NFRKB SMARCA4 SSBP2 POGZ BCL9 ZNF687 | 1.59e-09 | 166 | 83 | 10 | int:LHX4 |
| Interaction | KLF15 interactions | NCOR1 KMT2C MAZ NFRKB MAML1 POGZ BCL9 BCOR SAP130 NIPBL EP300 PRRC2B | 2.45e-09 | 290 | 83 | 12 | int:KLF15 |
| Interaction | TEAD1 interactions | 2.80e-09 | 176 | 83 | 10 | int:TEAD1 | |
| Interaction | TPRX2 interactions | 3.06e-09 | 56 | 83 | 7 | int:TPRX2 | |
| Interaction | OTUD4 interactions | LATS1 TIA1 ATXN2 NAF1 TNRC6A TNRC6B ANKRD17 UNK ZCCHC2 R3HDM1 PRRC2B | 3.46e-09 | 236 | 83 | 11 | int:OTUD4 |
| Interaction | ASF1A interactions | NCOR1 NCOA6 ARID1B NFRKB SMARCA4 CHD8 POGZ BCOR SAP130 EP300 ZNF687 | 6.06e-09 | 249 | 83 | 11 | int:ASF1A |
| Interaction | PRRC2B interactions | ATXN2 CECR2 TNRC6A TNRC6B ANKRD17 UNK WWTR1 R3HDM1 BCOR SF1 PRRC2B | 1.16e-08 | 265 | 83 | 11 | int:PRRC2B |
| Interaction | CPEB4 interactions | 1.60e-08 | 156 | 83 | 9 | int:CPEB4 | |
| Interaction | WWTR1 interactions | SCYL2 NCOR1 NCOA6 ARID1B LATS1 SMARCA4 TNRC6B CHD8 WWTR1 POGZ BCOR EP300 PRRC2B | 1.73e-08 | 422 | 83 | 13 | int:WWTR1 |
| Interaction | SEC16A interactions | SCYL2 SEC24D LATS1 ATXN2 KIAA1217 TNRC6A RBM14 TNRC6B WWTR1 TNRC6C BCOR MIDEAS PRRC2B | 1.94e-08 | 426 | 83 | 13 | int:SEC16A |
| Interaction | NFIX interactions | 3.20e-08 | 227 | 83 | 10 | int:NFIX | |
| Interaction | NUP43 interactions | BCL9L NCOR1 NCOA6 ARID1B DDX17 NFRKB RBM14 SMARCA4 TNRC6B CHD8 POGZ BCOR MIDEAS NIPBL ZNF687 | 3.45e-08 | 625 | 83 | 15 | int:NUP43 |
| Interaction | IRF4 interactions | 5.92e-08 | 85 | 83 | 7 | int:IRF4 | |
| Interaction | YTHDF3 interactions | ATXN2 TNRC6A TNRC6B ANKRD17 UNK TNRC6C ZCCHC2 R3HDM1 SF1 PRRC2B | 6.82e-08 | 246 | 83 | 10 | int:YTHDF3 |
| Interaction | TOP3B interactions | NCOR1 KMT2C NCOA6 VOPP1 TIA1 ATXN2 TMEM259 ZMIZ2 KAT6A RBM14 MAML1 TNRC6B ANKRD17 UNK CHD8 TNRC6C GNAS BCL9 EP300 PRRC2B ZNF687 SH3BP4 | 7.58e-08 | 1470 | 83 | 22 | int:TOP3B |
| Interaction | SMAP2 interactions | 8.39e-08 | 189 | 83 | 9 | int:SMAP2 | |
| Interaction | DTX2 interactions | BCL9L NCOR1 TNRC6A RBM14 WWTR1 POGZ R3HDM1 BCL9 BCOR SF1 SH3BP4 | 1.09e-07 | 330 | 83 | 11 | int:DTX2 |
| Interaction | SOX17 interactions | 1.28e-07 | 95 | 83 | 7 | int:SOX17 | |
| Interaction | DAZL interactions | 1.48e-07 | 145 | 83 | 8 | int:DAZL | |
| Interaction | SOX9 interactions | 1.48e-07 | 97 | 83 | 7 | int:SOX9 | |
| Interaction | SSBP4 interactions | 1.54e-07 | 59 | 83 | 6 | int:SSBP4 | |
| Interaction | CPEB1 interactions | 1.56e-07 | 146 | 83 | 8 | int:CPEB1 | |
| Interaction | FXR2 interactions | LATS1 DDX17 ATXN2 CECR2 KIAA1217 KAT6A CAPRIN2 RBM14 TNRC6B ANKRD17 UNK PRRC2B | 1.88e-07 | 430 | 83 | 12 | int:FXR2 |
| Interaction | TNRC6B interactions | LATS1 ATXN2 KAT6A TNRC6A TNRC6B ANKRD17 UNK WWTR1 TNRC6C PRRC2B | 2.43e-07 | 282 | 83 | 10 | int:TNRC6B |
| Interaction | PUM1 interactions | LATS1 ATXN2 TNRC6A TNRC6B ANKRD17 UNK TNRC6C R3HDM1 EP300 PRRC2B | 2.86e-07 | 287 | 83 | 10 | int:PUM1 |
| Interaction | EN1 interactions | 3.51e-07 | 110 | 83 | 7 | int:EN1 | |
| Interaction | KLF3 interactions | 4.12e-07 | 228 | 83 | 9 | int:KLF3 | |
| Interaction | CEP85 interactions | 4.79e-07 | 169 | 83 | 8 | int:CEP85 | |
| Interaction | MAML1 interactions | 5.55e-07 | 73 | 83 | 6 | int:MAML1 | |
| Interaction | CTBP1 interactions | NCOR1 TIA1 RBM14 MAML1 SEC31A MAML2 BCOR TBL1XR1 SF1 EP300 PRRC2B | 8.52e-07 | 406 | 83 | 11 | int:CTBP1 |
| Interaction | ATXN1 interactions | NCOR1 DDX17 ATXN2 KAT6A RBM14 SMARCA4 UNK POGZ SEC31A PAX7 GNAS R3HDM1 BCOR TBL1XR1 SAP130 SF1 PRRC2B | 9.15e-07 | 1039 | 83 | 17 | int:ATXN1 |
| Interaction | HNF1A interactions | 9.57e-07 | 80 | 83 | 6 | int:HNF1A | |
| Interaction | CREBBP interactions | CITED2 NCOR1 NCOA6 ARID1B LATS1 DDX17 KAT6A MAML1 SMARCA4 WWTR1 MAML2 PAX7 EP300 | 9.74e-07 | 599 | 83 | 13 | int:CREBBP |
| Interaction | GATA3 interactions | 1.03e-06 | 187 | 83 | 8 | int:GATA3 | |
| Interaction | R3HDM2 interactions | 1.04e-06 | 129 | 83 | 7 | int:R3HDM2 | |
| Interaction | NFIA interactions | 1.07e-06 | 188 | 83 | 8 | int:NFIA | |
| Interaction | HELZ interactions | 1.12e-06 | 257 | 83 | 9 | int:HELZ | |
| Interaction | LSM14A interactions | 1.23e-06 | 260 | 83 | 9 | int:LSM14A | |
| Interaction | R3HDM1 interactions | 1.28e-06 | 84 | 83 | 6 | int:R3HDM1 | |
| Interaction | PAX2 interactions | 1.37e-06 | 85 | 83 | 6 | int:PAX2 | |
| Interaction | MED23 interactions | 1.49e-06 | 266 | 83 | 9 | int:MED23 | |
| Interaction | GSC interactions | 1.57e-06 | 87 | 83 | 6 | int:GSC | |
| Interaction | NR3C1 interactions | NCOR1 NCOA6 ARID1B MED8 RBM14 MAML1 SMARCA4 ANKRD17 POGZ BCL9 BCOR NIPBL MAML3 EP300 PRRC2B ZNF687 | 1.92e-06 | 974 | 83 | 16 | int:NR3C1 |
| Interaction | SNRNP40 interactions | BCL9L NCOR1 ARID1B DDX17 ZMIZ2 KAT6A NFRKB RBM14 SMARCA4 POGZ BCL9 BCOR MIDEAS | 1.93e-06 | 637 | 83 | 13 | int:SNRNP40 |
| Interaction | TLX2 interactions | 1.97e-06 | 142 | 83 | 7 | int:TLX2 | |
| Interaction | HDAC1 interactions | NCOR1 DDX17 ZMIZ2 MED8 TNRC6A SMARCA4 TNRC6B ANKRD17 CHD8 BCOR KCTD11 MIDEAS TBL1XR1 SAP130 ZBTB1 EP300 ZNF687 | 2.20e-06 | 1108 | 83 | 17 | int:HDAC1 |
| Interaction | NCOA6 interactions | 2.27e-06 | 145 | 83 | 7 | int:NCOA6 | |
| Interaction | TNRC6A interactions | 2.27e-06 | 280 | 83 | 9 | int:TNRC6A | |
| Interaction | MYCN interactions | SEC24D ARID1B DDX17 TIA1 ATXN2 MAZ RBM14 SMARCA4 TNRC6B ANKRD17 TSPYL5 POGZ SEC31A TNRC6C R3HDM1 MIDEAS SF1 EP300 PRRC2B | 2.31e-06 | 1373 | 83 | 19 | int:MYCN |
| Interaction | CNOT6L interactions | 2.33e-06 | 93 | 83 | 6 | int:CNOT6L | |
| Interaction | NFIC interactions | 2.46e-06 | 210 | 83 | 8 | int:NFIC | |
| Interaction | TDRD3 interactions | 2.64e-06 | 212 | 83 | 8 | int:TDRD3 | |
| Interaction | SMC5 interactions | NCOR1 NCOA6 ARID1B DDX17 ATXN2 MAZ NFRKB RBM14 SMARCA4 CHD8 POGZ BCOR MIDEAS SAP130 NIPBL SF1 | 2.70e-06 | 1000 | 83 | 16 | int:SMC5 |
| Interaction | ZC3H7A interactions | 2.92e-06 | 215 | 83 | 8 | int:ZC3H7A | |
| Interaction | GLI3 interactions | 3.16e-06 | 98 | 83 | 6 | int:GLI3 | |
| Interaction | SS18L1 interactions | 3.16e-06 | 98 | 83 | 6 | int:SS18L1 | |
| Interaction | RC3H1 interactions | DDX17 ATXN2 MAZ NAF1 TNRC6A RBM14 TNRC6B ANKRD17 UNK TNRC6C R3HDM1 SF1 PRRC2B | 3.76e-06 | 677 | 83 | 13 | int:RC3H1 |
| Interaction | FXR1 interactions | NCOR1 ATXN2 CECR2 CAPRIN2 SMARCA4 TNRC6B ANKRD17 R3HDM1 BCOR IMMP2L ANKRD40 EP300 PRRC2B | 3.88e-06 | 679 | 83 | 13 | int:FXR1 |
| Interaction | MEN1 interactions | SCYL2 NCOR1 KMT2C NCOA6 ARID1B DDX17 TIA1 RBM14 SMARCA4 ANKRD17 CHD8 POGZ MIDEAS SAP130 SF1 ZNF687 | 3.89e-06 | 1029 | 83 | 16 | int:MEN1 |
| Interaction | MEX3A interactions | BCL9L DDX17 WDR20 KAT6A MTNR1A SMARCA4 UNK CHD8 EP300 PRRC2B | 3.96e-06 | 384 | 83 | 10 | int:MEX3A |
| Interaction | PRRC2A interactions | ATXN2 TNRC6A TNRC6B ANKRD17 UNK WWTR1 TNRC6C ZCCHC2 R3HDM1 PRRC2B | 4.44e-06 | 389 | 83 | 10 | int:PRRC2A |
| Interaction | PPARG interactions | 4.81e-06 | 307 | 83 | 9 | int:PPARG | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.43e-09 | 25 | 48 | 5 | 775 | |
| GeneFamily | Ankyrin repeat domain containing | 4.41e-04 | 242 | 48 | 5 | 403 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.15e-04 | 17 | 48 | 2 | 486 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 1.99e-03 | 25 | 48 | 2 | 74 | |
| GeneFamily | Cyclins|Mediator complex | 3.46e-03 | 33 | 48 | 2 | 1061 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.73e-03 | 53 | 48 | 2 | 532 | |
| Coexpression | BENPORATH_NANOG_TARGETS | CITED2 BCL9L NCOR1 VOPP1 ARID1B DDX17 TIA1 TMEM259 KIAA1217 WDR20 KAT6A TNRC6A RBM14 SSBP2 R3HDM1 BCL9 NFAT5 TBL1XR1 | 1.84e-09 | 988 | 84 | 18 | M6616 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CITED2 NCOR1 KMT2C VOPP1 LATS1 DDX17 PIK3R1 KAT6A TNRC6B TNRC6C GNAS NFAT5 MAPRE2 TBL1XR1 ZBTB1 NIPBL SF1 EP300 PRRC2B | 1.90e-07 | 1492 | 84 | 19 | M40023 |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 2.65e-07 | 200 | 84 | 8 | M5851 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 2.85e-06 | 192 | 84 | 7 | M8272 | |
| Coexpression | GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN | 3.74e-06 | 200 | 84 | 7 | M9486 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 4.10e-06 | 131 | 84 | 6 | M39232 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | CITED2 NCOR1 ARID1B LATS1 DDX17 ATXN2 KIAA1217 TNRC6B SSBP2 POGZ GNAS TBL1XR1 | 9.90e-06 | 807 | 84 | 12 | M16651 |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | BCL9L AMMECR1L CTTNBP2 TMEM259 TEDC2 MAZ CAPRIN2 CHD8 WWTR1 MIDEAS NFAT5 SAP130 PDZD4 | 1.04e-05 | 954 | 84 | 13 | MM3689 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.59e-05 | 166 | 84 | 6 | M6826 | |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 2.52e-05 | 180 | 84 | 6 | M8906 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 3.83e-05 | 194 | 84 | 6 | M3321 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 4.54e-05 | 200 | 84 | 6 | M9490 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 4.54e-05 | 200 | 84 | 6 | M5055 | |
| Coexpression | GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP | 4.54e-05 | 200 | 84 | 6 | M7064 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 4.54e-05 | 200 | 84 | 6 | M9273 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 9.21e-05 | 141 | 84 | 5 | M39235 | |
| Coexpression | KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN | 1.16e-04 | 342 | 84 | 7 | M41062 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.24e-04 | 240 | 84 | 6 | M39236 | |
| Coexpression | BILD_HRAS_ONCOGENIC_SIGNATURE | 1.62e-04 | 252 | 84 | 6 | M12029 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.98e-04 | 166 | 84 | 5 | M8129 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 1.98e-04 | 166 | 84 | 5 | M344 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 2.03e-04 | 167 | 84 | 5 | M361 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | NCOR1 SEC24D VOPP1 TIA1 CAPRIN2 SMARCA4 TSPYL5 WWTR1 GNAS BCOR | 2.16e-04 | 790 | 84 | 10 | M12490 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 2.27e-04 | 171 | 84 | 5 | M39234 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.88e-04 | 180 | 84 | 5 | M8239 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 3.37e-04 | 289 | 84 | 6 | M2196 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 3.44e-04 | 290 | 84 | 6 | M17183 | |
| Coexpression | IKEDA_MIR133_TARGETS_UP | 3.82e-04 | 44 | 84 | 3 | M2377 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SEC24D DDX17 TIA1 ATXN2 KAT6A ANKRD17 WWTR1 SSBP2 R3HDM1 NIPBL | 4.07e-04 | 856 | 84 | 10 | M4500 |
| Coexpression | IKEDA_MIR133_TARGETS_UP | 4.09e-04 | 45 | 84 | 3 | MM929 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 4.15e-04 | 195 | 84 | 5 | M7397 | |
| Coexpression | GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP | 4.25e-04 | 196 | 84 | 5 | M3668 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 4.25e-04 | 196 | 84 | 5 | M6111 | |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_UP | 4.38e-04 | 110 | 84 | 4 | M1696 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_DN | 4.45e-04 | 198 | 84 | 5 | M6255 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 4.56e-04 | 199 | 84 | 5 | M8606 | |
| Coexpression | GSE11924_TH1_VS_TH17_CD4_TCELL_DN | 4.56e-04 | 199 | 84 | 5 | M3163 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | 4.56e-04 | 199 | 84 | 5 | M3156 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 4.56e-04 | 199 | 84 | 5 | M6028 | |
| Coexpression | MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 | 4.65e-04 | 47 | 84 | 3 | M1652 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP | 4.66e-04 | 200 | 84 | 5 | M9495 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 4.66e-04 | 200 | 84 | 5 | M5069 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 4.66e-04 | 200 | 84 | 5 | M9453 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 4.66e-04 | 200 | 84 | 5 | M291 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 4.66e-04 | 200 | 84 | 5 | M3510 | |
| Coexpression | GSE27786_LSK_VS_NEUTROPHIL_UP | 4.66e-04 | 200 | 84 | 5 | M4760 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP | 4.66e-04 | 200 | 84 | 5 | M3749 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP | 4.66e-04 | 200 | 84 | 5 | M8567 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 4.66e-04 | 200 | 84 | 5 | M5529 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BASOPHIL_DN | 4.66e-04 | 200 | 84 | 5 | M5525 | |
| Coexpression | GSE17721_0.5H_VS_4H_LPS_BMDC_UP | 4.66e-04 | 200 | 84 | 5 | M4070 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 4.66e-04 | 200 | 84 | 5 | M9260 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 4.66e-04 | 200 | 84 | 5 | M4456 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 4.66e-04 | 200 | 84 | 5 | M4449 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 5.35e-04 | 116 | 84 | 4 | M2379 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 5.53e-04 | 117 | 84 | 4 | MM931 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 5.57e-04 | 208 | 84 | 5 | M39233 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.52e-06 | 210 | 82 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.19e-06 | 259 | 82 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | KMT2C AMMECR1L TIA1 ATXN2 PIK3R1 KIAA1217 TNRC6A SMARCA4 CHD8 SSBP2 FLRT1 R3HDM1 NFAT5 | 1.14e-05 | 801 | 82 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | NCOR1 VOPP1 PIK3R1 KIAA1217 RBM14 SSBP2 TNRC6C BCL9 BCOR NFAT5 MAPRE2 TBL1XR1 NIPBL | 1.45e-05 | 819 | 82 | 13 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | CITED2 NCOR1 AMMECR1L DDX17 TIA1 KIAA1217 MED12L SSBP2 NFAT5 | 1.55e-05 | 379 | 82 | 9 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 2.53e-05 | 150 | 82 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.05e-05 | 230 | 82 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 3.90e-05 | 162 | 82 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | KMT2C AMMECR1L TIA1 ATXN2 PIK3R1 KIAA1217 TNRC6A CHD8 SSBP2 FLRT1 R3HDM1 NFAT5 | 4.91e-05 | 790 | 82 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | KMT2C AMMECR1L TIA1 ATXN2 PIK3R1 CAPRIN2 SMARCA4 ANKRD17 CHD8 SSBP2 R3HDM1 NFAT5 | 5.21e-05 | 795 | 82 | 12 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | CITED2 NCOR1 AMMECR1L DDX17 TIA1 CECR2 KIAA1217 MED12L SSBP2 TNRC6C BCL9 NFAT5 | 5.21e-05 | 795 | 82 | 12 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.40e-05 | 275 | 82 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.08e-04 | 281 | 82 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | KMT2C AMMECR1L CTTNBP2 TIA1 PIK3R1 CAPRIN2 TNRC6A CHD8 SSBP2 R3HDM1 NFAT5 | 1.95e-04 | 778 | 82 | 11 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SCYL2 SMAP1 NCOA6 LATS1 CECR2 TNRC6B POGZ R3HDM1 ANKRD40 NIPBL MAML3 | 1.99e-04 | 780 | 82 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.43e-04 | 226 | 82 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | AMMECR1L TIA1 ATXN2 KIAA1217 TNRC6A SMARCA4 ANKRD17 CHD8 SSBP2 R3HDM1 KCTD11 | 2.64e-04 | 806 | 82 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | CITED2 SMAP1 ATXN2 PIK3R1 SMARCA4 CHD8 SSBP2 SEC31A NFAT5 ANKRD40 NIPBL | 3.03e-04 | 819 | 82 | 11 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 4.25e-04 | 163 | 82 | 5 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200 | 4.28e-04 | 91 | 82 | 4 | gudmap_developingGonad_e14.5_ epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 4.74e-04 | 167 | 82 | 5 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 4.84e-04 | 94 | 82 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_200 | 6.13e-04 | 43 | 82 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.18e-04 | 375 | 82 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.24e-04 | 492 | 82 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 6.57e-04 | 496 | 82 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_200 | 7.01e-04 | 45 | 82 | 3 | gudmap_developingGonad_e14.5_ ovary_200_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.13e-04 | 277 | 82 | 6 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 7.88e-04 | 107 | 82 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.12e-04 | 284 | 82 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.73e-04 | 288 | 82 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 9.43e-04 | 403 | 82 | 7 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 9.84e-04 | 406 | 82 | 7 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | KMT2C AMMECR1L TIA1 ATXN2 PIK3R1 KIAA1217 TNRC6A CHD8 SSBP2 R3HDM1 | 9.95e-04 | 799 | 82 | 10 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | TIA1 ATXN2 PIK3R1 KIAA1217 SMARCA4 ANKRD17 CHD8 SSBP2 R3HDM1 NFAT5 | 1.04e-03 | 804 | 82 | 10 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.09e-03 | 413 | 82 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.09e-03 | 201 | 82 | 5 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.14e-03 | 203 | 82 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-10 | 199 | 83 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.93e-09 | 200 | 83 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-08 | 189 | 83 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.29e-08 | 192 | 83 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.55e-08 | 193 | 83 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.55e-08 | 193 | 83 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.63e-08 | 200 | 83 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.63e-08 | 200 | 83 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.42e-06 | 188 | 83 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.60e-06 | 192 | 83 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 192 | 83 | 6 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-06 | 192 | 83 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.86e-06 | 197 | 83 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.92e-06 | 198 | 83 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-06 | 198 | 83 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-05 | 88 | 83 | 4 | 142d2e00ef19c0ad011a21945bf1111271056eae | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-05 | 186 | 83 | 5 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.56e-05 | 186 | 83 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.56e-05 | 186 | 83 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 193 | 83 | 5 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 194 | 83 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.21e-05 | 195 | 83 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| Computational | Neighborhood of NUMA1 | 1.60e-04 | 56 | 53 | 4 | GCM_NUMA1 | |
| Drug | cerous chloride | 4.17e-06 | 177 | 84 | 7 | ctd:C026690 | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 6.88e-06 | 191 | 84 | 7 | 4303_DN | |
| Drug | novobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A | 8.70e-06 | 198 | 84 | 7 | 342_UP | |
| Drug | AC1L2E0P | 1.79e-05 | 307 | 84 | 8 | CID000019390 | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 6.97e-05 | 188 | 84 | 6 | 4835_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 7.39e-05 | 190 | 84 | 6 | 4306_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 7.61e-05 | 191 | 84 | 6 | 7379_DN | |
| Drug | halofenate | 8.03e-05 | 4 | 84 | 2 | CID000033584 | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | 8.06e-05 | 193 | 84 | 6 | 1228_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.29e-05 | 194 | 84 | 6 | 3747_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 8.29e-05 | 194 | 84 | 6 | 4309_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 8.29e-05 | 194 | 84 | 6 | 4272_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A | 8.53e-05 | 195 | 84 | 6 | 1927_UP | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HG-U133A | 8.53e-05 | 195 | 84 | 6 | 1942_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 7124_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 1861_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 7425_UP | |
| Drug | Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; HL60; HG-U133A | 9.02e-05 | 197 | 84 | 6 | 1564_UP | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HG-U133A | 9.02e-05 | 197 | 84 | 6 | 1944_DN | |
| Drug | rofecoxib; Down 200; 10uM; PC3; HG-U133A | 9.02e-05 | 197 | 84 | 6 | 463_DN | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 7428_UP | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; HL60; HG-U133A | 9.28e-05 | 198 | 84 | 6 | 2014_UP | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 4567_DN | |
| Drug | Diazoxide [364-98-7]; Up 200; 17.4uM; HL60; HG-U133A | 9.81e-05 | 200 | 84 | 6 | 1368_UP | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.81e-05 | 200 | 84 | 6 | 4505_DN | |
| Disease | urate measurement | NCOA6 ATXN2 PIK3R1 WDR20 ILDR1 FLRT1 PAX7 GNAS NFAT5 DYDC2 SF1 PRRC2B | 5.11e-06 | 895 | 80 | 12 | EFO_0004531 |
| Disease | Neurodevelopmental Disorders | 5.57e-06 | 93 | 80 | 5 | C1535926 | |
| Disease | Adenoid Cystic Carcinoma | 7.94e-06 | 100 | 80 | 5 | C0010606 | |
| Disease | Motor delay | 2.17e-05 | 3 | 80 | 2 | C1854301 | |
| Disease | diet measurement | SCYL2 NCOA6 ARID1B CTTNBP2 PIK3R1 KIAA1217 TNRC6A SMARCA4 TNRC6B ZCCHC2 NIPBL MAML3 | 2.49e-05 | 1049 | 80 | 12 | EFO_0008111 |
| Disease | smoking cessation | 2.94e-05 | 325 | 80 | 7 | EFO_0004319 | |
| Disease | mental development measurement | 4.23e-05 | 25 | 80 | 3 | EFO_0008230 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 7.22e-05 | 5 | 80 | 2 | C3281201 | |
| Disease | Alveolar rhabdomyosarcoma | 7.22e-05 | 5 | 80 | 2 | C0206655 | |
| Disease | cancer (implicated_via_orthology) | 9.09e-05 | 268 | 80 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | body weight | NCOR1 PIK3R1 KIAA1217 ZMIZ2 HDX TNRC6A TNRC6B CHD8 SSBP2 GNAS NIPBL MAML3 | 1.44e-04 | 1261 | 80 | 12 | EFO_0004338 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.90e-04 | 41 | 80 | 3 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 1.90e-04 | 41 | 80 | 3 | C0007138 | |
| Disease | Breast adenocarcinoma | 1.90e-04 | 41 | 80 | 3 | C0858252 | |
| Disease | gallstones | 2.17e-04 | 108 | 80 | 4 | EFO_0004210 | |
| Disease | Liver Diseases, Parasitic | 2.58e-04 | 9 | 80 | 2 | C0023897 | |
| Disease | hematocrit | ARID1B DDX17 ATXN2 ZMIZ2 TNRC6B ANKRD17 ILDR1 MAML2 NFAT5 DYDC2 | 4.00e-04 | 1011 | 80 | 10 | EFO_0004348 |
| Disease | Diffuse Large B-Cell Lymphoma | 4.55e-04 | 55 | 80 | 3 | C0079744 | |
| Disease | facial morphology | 4.55e-04 | 55 | 80 | 3 | EFO_0004743 | |
| Disease | event free survival time, type 1 diabetes mellitus, autoantibody measurement | 4.71e-04 | 12 | 80 | 2 | EFO_0000482, EFO_0004866, MONDO_0005147 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 5.55e-04 | 13 | 80 | 2 | OBA_2045174 | |
| Disease | Coffin-Siris syndrome | 5.55e-04 | 13 | 80 | 2 | C0265338 | |
| Disease | Bladder Neoplasm | 5.81e-04 | 140 | 80 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 5.96e-04 | 141 | 80 | 4 | C0005684 | |
| Disease | Sarcoma, Spindle Cell | 6.47e-04 | 14 | 80 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 6.47e-04 | 14 | 80 | 2 | C0205944 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 6.47e-04 | 14 | 80 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Muscular Atrophy | 7.45e-04 | 15 | 80 | 2 | C0026846 | |
| Disease | Neurogenic Muscular Atrophy | 7.45e-04 | 15 | 80 | 2 | C0270948 | |
| Disease | Burkitt Leukemia | 7.45e-04 | 15 | 80 | 2 | C4721444 | |
| Disease | African Burkitt's lymphoma | 7.45e-04 | 15 | 80 | 2 | C0343640 | |
| Disease | vitamin K-dependent protein C measurement | 7.45e-04 | 15 | 80 | 2 | EFO_0008318 | |
| Disease | cystatin C measurement | 7.92e-04 | 402 | 80 | 6 | EFO_0004617 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 8.50e-04 | 16 | 80 | 2 | OBA_2045195 | |
| Disease | prostate cancer (is_marker_for) | 8.70e-04 | 156 | 80 | 4 | DOID:10283 (is_marker_for) | |
| Disease | congenital heart disease (implicated_via_orthology) | 8.84e-04 | 69 | 80 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | osteoarthritis, knee | 9.12e-04 | 158 | 80 | 4 | EFO_0004616 | |
| Disease | ischemia (implicated_via_orthology) | 9.61e-04 | 17 | 80 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | NCOR1 ARID1B CTTNBP2 ATXN2 PIK3R1 TNRC6A TNRC6B SSBP2 ACTRT2 PAX7 MAPRE2 | 9.89e-04 | 1345 | 80 | 11 | EFO_0010736 |
| Disease | obsolete_red blood cell distribution width | TMEM259 PIK3R1 KIAA1217 WDR20 NFRKB ZCCHC2 R3HDM1 MIDEAS MAPRE2 TBL1XR1 EP300 | 1.00e-03 | 1347 | 80 | 11 | EFO_0005192 |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 1.08e-03 | 18 | 80 | 2 | OBA_2045175 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 1.20e-03 | 19 | 80 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | Leukemia, Myelocytic, Acute | 1.28e-03 | 173 | 80 | 4 | C0023467 | |
| Disease | household income | 1.44e-03 | 304 | 80 | 5 | EFO_0009695 | |
| Disease | Sarcoma | 1.47e-03 | 21 | 80 | 2 | C1261473 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.48e-03 | 801 | 80 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Autism Spectrum Disorders | 1.62e-03 | 85 | 80 | 3 | C1510586 | |
| Disease | clinical and behavioural ideal cardiovascular health | 1.77e-03 | 23 | 80 | 2 | EFO_0007654 | |
| Disease | cholelithiasis | 1.78e-03 | 88 | 80 | 3 | EFO_0004799 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.93e-03 | 24 | 80 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.93e-03 | 24 | 80 | 2 | C3805278 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.98e-03 | 195 | 80 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 2.26e-03 | 26 | 80 | 2 | EFO_0008007, EFO_0021497 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 2.26e-03 | 26 | 80 | 2 | OBA_2045194 | |
| Disease | unipolar depression, depressive symptom measurement | 2.26e-03 | 26 | 80 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | Cholangiocarcinoma | 2.26e-03 | 26 | 80 | 2 | C0206698 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.29e-03 | 670 | 80 | 7 | EFO_0006335, EFO_0006336 | |
| Disease | Adenocarcinoma of large intestine | 2.29e-03 | 96 | 80 | 3 | C1319315 | |
| Disease | Sezary Syndrome | 2.44e-03 | 27 | 80 | 2 | C0036920 | |
| Disease | alpha fetoprotein measurement | 2.57e-03 | 100 | 80 | 3 | EFO_0010583 | |
| Disease | glomerular filtration rate, response to platinum based chemotherapy | 2.62e-03 | 28 | 80 | 2 | EFO_0004647, EFO_0005208 | |
| Disease | myocardial infarction | 2.65e-03 | 350 | 80 | 5 | EFO_0000612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDAGAQQNPQPSPEG | 396 | Q8N6Y0 | |
| GQPMSPQLRQTQGLP | 421 | P84996 | |
| SQGGLPQPQQLQSGM | 1996 | Q09472 | |
| SSVQQAQIMGPGQSP | 376 | Q9HCK8 | |
| PGNSPITRMNPASGA | 71 | Q6DCA0 | |
| PQQLGSQSPGLSNMV | 266 | Q8TDY3 | |
| SARQGQMQGIPAPSQ | 341 | P0CJ87 | |
| GSQMPPQPPGSQSES | 831 | Q8NFD5 | |
| AQMQNGGPSTPPASP | 141 | Q6AI12 | |
| PQQTAAQMGFAPIQP | 941 | O75179 | |
| VPGPSPNEENNGKSM | 511 | Q6W2J9 | |
| GGTPSQAPFLNQMRP | 636 | Q9BXF3 | |
| QPVMFPNQSNQGSMP | 751 | Q15032 | |
| PNQSNQGSMPTTGMP | 756 | Q15032 | |
| MSQGAVANANSTPPP | 561 | Q96PK6 | |
| GASMQPSLNPGGSQS | 41 | Q96T52 | |
| PSNHMNPVSNGLSPQ | 371 | P23759 | |
| ARPQPTPSGSMQQAN | 26 | Q8N9V6 | |
| MLQNPQQATPAPAPG | 411 | Q92585 | |
| HQGMPNLSGQTPGNS | 841 | Q92585 | |
| IQSPLTPQPGNGNMS | 1806 | Q8NEZ4 | |
| TPQPGNGNMSPAQSF | 1811 | Q8NEZ4 | |
| MNNPVGLPQHFSPQS | 2531 | Q8NEZ4 | |
| ENQSTTLPGPGRNMP | 336 | Q7Z353 | |
| QVAPSSLPMPGGNTA | 401 | Q86YW9 | |
| VPQQSGGPAQTLPQM | 816 | Q6P4R8 | |
| MPSLPGQQGTSQARP | 1031 | Q96JK9 | |
| PGMPAFSQPPAQQQI | 1056 | Q96JK9 | |
| NTSPMNPPNQGQRGI | 306 | O95835 | |
| GMPQQVPPSESAGQI | 131 | Q96IM9 | |
| QAQPSPSMVGHQQPT | 941 | Q99700 | |
| MAGNSNLNRTPPGPA | 496 | Q76G19 | |
| PMTQTTNQPPIANGV | 271 | Q86SU0 | |
| VPPQTSSGNRFMPQQ | 156 | Q6KC79 | |
| SSGNRFMPQQNSPVP | 161 | Q6KC79 | |
| GLMNSFPPPQGHAQN | 26 | P56270 | |
| MPSNSGNLQKQAPPN | 796 | Q9Y5G1 | |
| PPKPTTVANNGMNNN | 311 | P27986 | |
| GSLPPNPMPQSQQGT | 1216 | O94916 | |
| SPLYSPQNNMPGIQG | 1396 | O94916 | |
| PQNNMPGIQGATSSP | 1401 | O94916 | |
| MAISQPGQPQNEGQP | 1471 | O94916 | |
| PTGTPQQAQPDSMLG | 786 | Q9NYA4 | |
| GQQTFSPQSSPMPGV | 486 | Q8IZL2 | |
| GFQQPVSSPGRNPMV | 466 | Q14686 | |
| LSNMQGQPQQGPPSQ | 606 | Q14686 | |
| MLPQQGPVNNSPSQV | 766 | Q14686 | |
| GPVNNSPSQVMGIQG | 771 | Q14686 | |
| PNGNQMSCGQNPGFP | 861 | Q14686 | |
| AGTPQAQATMTPPPN | 1801 | Q92794 | |
| QTPGIAPQNSQAPPM | 411 | Q8WZ74 | |
| MGINTQNPRISGPNP | 1056 | O00512 | |
| LSHSNQMPSPNAVGP | 1086 | O00512 | |
| QGSGPGISNSQPSQM | 1131 | Q86UU0 | |
| PNPPMAKGSEQGFQS | 731 | Q6IMN6 | |
| MPGPTQTLSPNGENN | 1 | Q15555 | |
| GPGTPTALPDDMNNN | 471 | Q4ZIN3 | |
| SMPQQPSQQPQDFGL | 276 | Q6PJG2 | |
| PLMSQQFAQPPGATN | 691 | Q92841 | |
| GPTTTLNQEQNAGPM | 506 | Q9NZU1 | |
| AGAPSQQQPMLSGVQ | 226 | Q96G25 | |
| FRAGTPMPPNLNSQG | 6 | Q693B1 | |
| ASSQPGQGNIQMINP | 61 | Q9NXJ0 | |
| SPNNMSLSNQPGTPR | 321 | P81877 | |
| TDGPNNTNPMNSSPN | 181 | Q9HCJ0 | |
| QTNPFLNGNVPVMPS | 166 | Q9P0V3 | |
| NMQTASGGPQPRLSA | 246 | Q7L2K0 | |
| QNPAPGLGTMVTQPV | 111 | Q7Z3K3 | |
| PQQQLPPSSQAEGMG | 2026 | O75376 | |
| QPGPSQSGPSQSRMR | 111 | Q86VE3 | |
| PGMSQQVPSQPGIRQ | 216 | Q86VE3 | |
| AASPVMPPQTQSPGQ | 321 | P51532 | |
| QAPQSPQIPMNGSAM | 931 | Q5T5P2 | |
| NQFVPPQGSPTMGSS | 866 | Q6P3W7 | |
| TNVMNATSPPAGSNG | 401 | Q8TBZ3 | |
| PTGPGTNNPNANLML | 401 | Q9BZK7 | |
| PPQQANSGPQMAGAQ | 221 | O94855 | |
| PPVASQGGSLPASMQ | 101 | Q99967 | |
| NANGTVVPPQQMGSG | 996 | Q9C0B9 | |
| MAFQVPPNSPQGSVA | 136 | Q96AW1 | |
| PPGVSQNLLANPMSN | 206 | Q76KD6 | |
| PINTQGLQPAPMGTQ | 596 | Q9H0E3 | |
| PMGTQQPQPEGKTSA | 606 | Q9H0E3 | |
| PQSGSPYQPMSGNQA | 2036 | Q5JSZ5 | |
| QQSTPGVFMGPTNIP | 316 | Q8IYB5 | |
| PLQQGMTQSLSVPGP | 311 | Q8NF64 | |
| GLENMRPPNNSSPVQ | 401 | Q9Y2K1 | |
| LAQENGPGMQPPVSS | 201 | Q8N1G0 | |
| VQQPLGQTGMPPSFS | 1066 | O94979 | |
| PSPVGTSSVPGMNAN | 486 | Q9C0B0 | |
| AAASPGAPQMQGNPT | 551 | Q15637 | |
| GQPQNITTEMTGPNN | 441 | Q8NDV7 | |
| GMQQPPAQPLSSSQP | 1346 | Q8NDV7 | |
| QLQSMQTESPGPSGN | 66 | Q8IV31 | |
| PNYGVQPPQGQNGSM | 356 | P31483 | |
| GNTPANAPNAMKPNS | 976 | Q9UPQ9 | |
| QQNHPTQNPPAGLMS | 206 | Q9GZV5 | |
| PGKQPMETTQPGVSQ | 401 | Q86VY4 | |
| MQGNGSALPNASQPV | 1 | P48039 | |
| TSGFPSQRQNNPIMP | 406 | Q96HR8 | |
| NVNTPSMTPVIGQPQ | 116 | Q9BZQ4 |